JP2001311092A - Bactericidal compound-containing composition - Google Patents
Bactericidal compound-containing compositionInfo
- Publication number
- JP2001311092A JP2001311092A JP2000130387A JP2000130387A JP2001311092A JP 2001311092 A JP2001311092 A JP 2001311092A JP 2000130387 A JP2000130387 A JP 2000130387A JP 2000130387 A JP2000130387 A JP 2000130387A JP 2001311092 A JP2001311092 A JP 2001311092A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- ethylene oxide
- compound
- methyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 117
- 150000001875 compounds Chemical class 0.000 title claims abstract description 72
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 48
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 43
- 150000003839 salts Chemical class 0.000 claims abstract description 20
- 230000001954 sterilising effect Effects 0.000 claims abstract 2
- -1 alkyl ethoxy sulfate Chemical compound 0.000 claims description 58
- 125000004432 carbon atom Chemical group C* 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 9
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 8
- 230000000855 fungicidal effect Effects 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 239000011593 sulfur Substances 0.000 claims description 5
- 229940043810 zinc pyrithione Drugs 0.000 claims description 5
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims description 5
- YMTZCQOAGFRQHV-UHFFFAOYSA-N 3-methyl-4,5-dihydro-1,2-thiazole Chemical compound CC1=NSCC1 YMTZCQOAGFRQHV-UHFFFAOYSA-N 0.000 claims description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 4
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 4
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 4
- 239000000417 fungicide Substances 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- 229960003500 triclosan Drugs 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960001325 triclocarban Drugs 0.000 claims description 3
- GDXCHXZXSDPUCJ-UHFFFAOYSA-N 3-chloro-4-methyl-4,5-dihydro-1,2-thiazole Chemical compound CC1CSN=C1Cl GDXCHXZXSDPUCJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 abstract description 19
- 238000005187 foaming Methods 0.000 abstract description 17
- 239000006260 foam Substances 0.000 abstract description 15
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract description 5
- 230000001747 exhibiting effect Effects 0.000 abstract 3
- 238000004321 preservation Methods 0.000 abstract 1
- 238000003860 storage Methods 0.000 description 25
- 238000009826 distribution Methods 0.000 description 21
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 17
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000002453 shampoo Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229960003237 betaine Drugs 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 239000012459 cleaning agent Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 150000008051 alkyl sulfates Chemical class 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- ICHUMRJJFKQBGK-UHFFFAOYSA-N dodecyl ethoxy sulfate Chemical compound CCCCCCCCCCCCOS(=O)(=O)OOCC ICHUMRJJFKQBGK-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 3
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical class ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 150000001768 cations Chemical group 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229940055577 oleyl alcohol Drugs 0.000 description 3
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 3
- 125000006353 oxyethylene group Chemical group 0.000 description 3
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- NJPQAIBZIHNJDO-UHFFFAOYSA-N 1-dodecylpyrrolidin-2-one Chemical compound CCCCCCCCCCCCN1CCCC1=O NJPQAIBZIHNJDO-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000005018 aryl alkenyl group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- QVWDCUMRWIBGJX-UHFFFAOYSA-N 1-hydroxy-4,6-dimethylpyridin-2-one Chemical compound CC=1C=C(C)N(O)C(=O)C=1 QVWDCUMRWIBGJX-UHFFFAOYSA-N 0.000 description 1
- VBAHGZFODNVOAQ-UHFFFAOYSA-N 1-hydroxy-4,6-diphenylpyridin-2-one Chemical compound C=1C(=O)N(O)C(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 VBAHGZFODNVOAQ-UHFFFAOYSA-N 0.000 description 1
- SNHWDNDKRMTYNV-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-(1-methylcyclohexyl)pyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1(C)CCCCC1 SNHWDNDKRMTYNV-UHFFFAOYSA-N 0.000 description 1
- DJOBTQHCXITUIN-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-(2-phenylethenyl)pyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C=CC1=CC=CC=C1 DJOBTQHCXITUIN-UHFFFAOYSA-N 0.000 description 1
- CRZPSVLEBAJKMN-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-(4-methylphenyl)pyridin-2-one Chemical compound C1=CC(C)=CC=C1C1=CC(C)=CC(=O)N1O CRZPSVLEBAJKMN-UHFFFAOYSA-N 0.000 description 1
- KETRKBRJHATKOE-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-(4-phenylbuta-1,3-dienyl)pyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C=CC=CC1=CC=CC=C1 KETRKBRJHATKOE-UHFFFAOYSA-N 0.000 description 1
- CBAIZBBKYBHCLT-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-(phenoxymethyl)pyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1COC1=CC=CC=C1 CBAIZBBKYBHCLT-UHFFFAOYSA-N 0.000 description 1
- XFJMASHZLCWQOQ-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-[(2,4,5-trichlorophenoxy)methyl]pyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1COC1=CC(Cl)=C(Cl)C=C1Cl XFJMASHZLCWQOQ-UHFFFAOYSA-N 0.000 description 1
- OWEMAELSDQIDCG-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-[(3-methylphenoxy)methyl]pyridin-2-one Chemical compound CC1=CC=CC(OCC=2N(C(=O)C=C(C)C=2)O)=C1 OWEMAELSDQIDCG-UHFFFAOYSA-N 0.000 description 1
- KQTIFPFGMJXMMA-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-[(4-methylphenyl)sulfanylmethyl]pyridin-2-one Chemical compound C1=CC(C)=CC=C1SCC1=CC(C)=CC(=O)N1O KQTIFPFGMJXMMA-UHFFFAOYSA-N 0.000 description 1
- JKMRCJRIHNVPKE-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-[1-(4-nitrophenoxy)butyl]pyridin-2-one Chemical compound C=1C(C)=CC(=O)N(O)C=1C(CCC)OC1=CC=C([N+]([O-])=O)C=C1 JKMRCJRIHNVPKE-UHFFFAOYSA-N 0.000 description 1
- CROKGKMYGXHLHB-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-naphthalen-2-ylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1=CC=C(C=CC=C2)C2=C1 CROKGKMYGXHLHB-UHFFFAOYSA-N 0.000 description 1
- ZBIMYUJKHIXXSK-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-oct-1-enylpyridin-2-one Chemical compound CCCCCCC=CC1=CC(C)=CC(=O)N1O ZBIMYUJKHIXXSK-UHFFFAOYSA-N 0.000 description 1
- ZZMUCXIMYNXQMO-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-prop-1-enylpyridin-2-one Chemical compound CC=CC1=CC(C)=CC(=O)N1O ZZMUCXIMYNXQMO-UHFFFAOYSA-N 0.000 description 1
- QHCSPVRVAUBWQV-UHFFFAOYSA-N 1-hydroxy-4-methyl-6-undecylpyridin-2-one Chemical compound CCCCCCCCCCCC1=CC(C)=CC(=O)N1O QHCSPVRVAUBWQV-UHFFFAOYSA-N 0.000 description 1
- AFXHVMLWGXYZJA-UHFFFAOYSA-N 1-hydroxy-4-methylpyridin-2-one Chemical compound CC=1C=CN(O)C(=O)C=1 AFXHVMLWGXYZJA-UHFFFAOYSA-N 0.000 description 1
- YDYNCCCWYVEDEH-UHFFFAOYSA-N 1-hydroxy-6-[2-(4-methoxyphenyl)ethenyl]-4-methylpyridin-2-one Chemical compound C1=CC(OC)=CC=C1C=CC1=CC(C)=CC(=O)N1O YDYNCCCWYVEDEH-UHFFFAOYSA-N 0.000 description 1
- QOWMEPRCLLJPTC-UHFFFAOYSA-N 1-hydroxy-6-methyl-4-phenylpyridin-2-one Chemical compound O=C1N(O)C(C)=CC(C=2C=CC=CC=2)=C1 QOWMEPRCLLJPTC-UHFFFAOYSA-N 0.000 description 1
- IEFRQNQEFHXQTF-UHFFFAOYSA-N 1-hydroxy-6-methylpyridin-2-one Chemical compound CC1=CC=CC(=O)N1O IEFRQNQEFHXQTF-UHFFFAOYSA-N 0.000 description 1
- MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 1
- KKFDCBRMNNSAAW-UHFFFAOYSA-N 2-(morpholin-4-yl)ethanol Chemical compound OCCN1CCOCC1 KKFDCBRMNNSAAW-UHFFFAOYSA-N 0.000 description 1
- BQJLEQAXRYBKPQ-UHFFFAOYSA-N 2-amino-2-methylpropane-1,1-diol Chemical compound CC(C)(N)C(O)O BQJLEQAXRYBKPQ-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- PYSGFFTXMUWEOT-UHFFFAOYSA-N 3-(dimethylamino)propan-1-ol Chemical compound CN(C)CCCO PYSGFFTXMUWEOT-UHFFFAOYSA-N 0.000 description 1
- LVEJKRJWFCXBBV-UHFFFAOYSA-N 3-chloro-4,5-dihydro-1,2-thiazole Chemical compound ClC1=NSCC1 LVEJKRJWFCXBBV-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- KSMVBYPXNKCPAJ-UHFFFAOYSA-N 4-Methylcyclohexylamine Chemical compound CC1CCC(N)CC1 KSMVBYPXNKCPAJ-UHFFFAOYSA-N 0.000 description 1
- BSTLMAXBSHHEIF-UHFFFAOYSA-N 4-[(1-hydroxy-4-methyl-6-oxopyridin-2-yl)methoxy]benzonitrile Chemical compound ON1C(=O)C=C(C)C=C1COC1=CC=C(C#N)C=C1 BSTLMAXBSHHEIF-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- PQXVGGAUYHGICP-UHFFFAOYSA-N 6-(2,2-dimethyl-1-phenylpropyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C(C(C)(C)C)C1=CC=CC=C1 PQXVGGAUYHGICP-UHFFFAOYSA-N 0.000 description 1
- HSYBITQOTFCWAZ-UHFFFAOYSA-N 6-(2-butylhex-1-enyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound CCCCC(CCCC)=CC1=CC(C)=CC(=O)N1O HSYBITQOTFCWAZ-UHFFFAOYSA-N 0.000 description 1
- ZRSSUJPAKAOGBP-UHFFFAOYSA-N 6-(3,5-dichlorophenyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1=CC(Cl)=CC(Cl)=C1 ZRSSUJPAKAOGBP-UHFFFAOYSA-N 0.000 description 1
- QFCNBUHEKPMPTR-UHFFFAOYSA-N 6-(3-bromo-4-chlorophenyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1=CC=C(Cl)C(Br)=C1 QFCNBUHEKPMPTR-UHFFFAOYSA-N 0.000 description 1
- KSGBFSAQWCOCIJ-UHFFFAOYSA-N 6-(4-chloro-3-methylphenyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1=CC=C(Cl)C(C)=C1 KSGBFSAQWCOCIJ-UHFFFAOYSA-N 0.000 description 1
- MOASYRUDTPYDDJ-UHFFFAOYSA-N 6-(4-tert-butylphenyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1=CC=C(C(C)(C)C)C=C1 MOASYRUDTPYDDJ-UHFFFAOYSA-N 0.000 description 1
- IIQCUCYKRFXIHP-UHFFFAOYSA-N 6-(benzenesulfonylmethyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1CS(=O)(=O)C1=CC=CC=C1 IIQCUCYKRFXIHP-UHFFFAOYSA-N 0.000 description 1
- IMNLMKIYPMXQHN-UHFFFAOYSA-N 6-(cyclohex-2-en-1-ylidenemethyl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C=C1C=CCCC1 IMNLMKIYPMXQHN-UHFFFAOYSA-N 0.000 description 1
- GRPQGRFHGIHWTA-UHFFFAOYSA-N 6-(furan-2-yl)-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C1=CC=CO1 GRPQGRFHGIHWTA-UHFFFAOYSA-N 0.000 description 1
- PEJAVDFRDVIARZ-UHFFFAOYSA-N 6-[(2,4-dimethylphenyl)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound CC1=CC(C)=CC=C1CC1=CC(C)=CC(=O)N1O PEJAVDFRDVIARZ-UHFFFAOYSA-N 0.000 description 1
- QFJNZIAAWICDQZ-UHFFFAOYSA-N 6-[(2,5-dichlorophenyl)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1CC1=CC(Cl)=CC=C1Cl QFJNZIAAWICDQZ-UHFFFAOYSA-N 0.000 description 1
- QKOQVNBLIREPBG-UHFFFAOYSA-N 6-[(2-chlorophenyl)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1CC1=CC=CC=C1Cl QKOQVNBLIREPBG-UHFFFAOYSA-N 0.000 description 1
- XBRDTHCRVKZGGP-UHFFFAOYSA-N 6-[(4-bromophenoxy)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1COC1=CC=C(Br)C=C1 XBRDTHCRVKZGGP-UHFFFAOYSA-N 0.000 description 1
- ZEKPAZGZUTXMLV-UHFFFAOYSA-N 6-[(4-bromophenyl)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1CC1=CC=C(Br)C=C1 ZEKPAZGZUTXMLV-UHFFFAOYSA-N 0.000 description 1
- SDGKMYQTUPUWHJ-UHFFFAOYSA-N 6-[(4-butan-2-ylphenoxy)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound C1=CC(C(C)CC)=CC=C1OCC1=CC(C)=CC(=O)N1O SDGKMYQTUPUWHJ-UHFFFAOYSA-N 0.000 description 1
- WCXCSGRTWNVHHT-UHFFFAOYSA-N 6-[(4-chlorophenyl)methyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1CC1=CC=C(Cl)C=C1 WCXCSGRTWNVHHT-UHFFFAOYSA-N 0.000 description 1
- UGNNVRXABMWTSC-UHFFFAOYSA-N 6-[(4-chlorophenyl)sulfanylmethyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1CSC1=CC=C(Cl)C=C1 UGNNVRXABMWTSC-UHFFFAOYSA-N 0.000 description 1
- FCHGQHPYGLEBDO-UHFFFAOYSA-N 6-[1-(4-chlorophenyl)sulfonylbutyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound C=1C=C(Cl)C=CC=1S(=O)(=O)C(CCC)C1=CC(C)=CC(=O)N1O FCHGQHPYGLEBDO-UHFFFAOYSA-N 0.000 description 1
- NQWAAYIRALCSMU-UHFFFAOYSA-N 6-[2-(furan-2-yl)ethenyl]-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C=CC1=CC=CO1 NQWAAYIRALCSMU-UHFFFAOYSA-N 0.000 description 1
- YLAIVCLTTYMFTQ-UHFFFAOYSA-N 6-benzhydryl-1-hydroxy-4-methylpyridin-2-one Chemical compound ON1C(=O)C=C(C)C=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 YLAIVCLTTYMFTQ-UHFFFAOYSA-N 0.000 description 1
- PRSLAOFFOCONKS-UHFFFAOYSA-N 6-heptan-3-yl-1-hydroxy-4-methylpyridin-2-one Chemical compound CCCCC(CC)C1=CC(C)=CC(=O)N1O PRSLAOFFOCONKS-UHFFFAOYSA-N 0.000 description 1
- BHJSVHSYLOKRJP-UHFFFAOYSA-N 6-heptyl-1-hydroxy-4-methylpyridin-2-one Chemical compound CCCCCCCC1=CC(C)=CC(=O)N1O BHJSVHSYLOKRJP-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- FDQGNLOWMMVRQL-UHFFFAOYSA-N Allobarbital Chemical compound C=CCC1(CC=C)C(=O)NC(=O)NC1=O FDQGNLOWMMVRQL-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 101100321669 Fagopyrum esculentum FA02 gene Proteins 0.000 description 1
- 101100321670 Fagopyrum esculentum FA18 gene Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 101000650817 Homo sapiens Semaphorin-4D Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- SZEXXTYGQYKIHJ-UHFFFAOYSA-N O.O.O.O.[Na].[Na].[Na].[Na] Chemical compound O.O.O.O.[Na].[Na].[Na].[Na] SZEXXTYGQYKIHJ-UHFFFAOYSA-N 0.000 description 1
- PMRAUCWLRYKVPF-UHFFFAOYSA-N ON1C(C=C(C=C1CC(C)C1CCC(CC1)(C)C)C)=O Chemical compound ON1C(C=C(C=C1CC(C)C1CCC(CC1)(C)C)C)=O PMRAUCWLRYKVPF-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710199886 Protein 0.5 Proteins 0.000 description 1
- AVLZAVSZOAQKRC-UHFFFAOYSA-N SYC-435 Chemical compound ON1C(=O)C=C(C)C=C1CC1=CC=CC=C1 AVLZAVSZOAQKRC-UHFFFAOYSA-N 0.000 description 1
- 102100027744 Semaphorin-4D Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- LGVFJHCENRNEOH-UHFFFAOYSA-N [O-]C(CC[N+]1(CCO)C=NCC1)=O Chemical compound [O-]C(CC[N+]1(CCO)C=NCC1)=O LGVFJHCENRNEOH-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 1
- 235000020242 coleus extract Nutrition 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 229950010007 dimantine Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 1
- HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229950004864 olamine Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XWJWAIUJSHLGJH-UHFFFAOYSA-M potassium 3-(2-oxotridecylamino)propanoate Chemical compound [K+].C(CCCCCCCCCCC)(=O)CNCCC(=O)[O-] XWJWAIUJSHLGJH-UHFFFAOYSA-M 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- WNEHWYCWKDNRFW-UQKRIMTDSA-M potassium;(4s)-4-(dodecanoylamino)-5-hydroxy-5-oxopentanoate Chemical compound [H+].[K+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WNEHWYCWKDNRFW-UQKRIMTDSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- ZSSZUMCXBONOBH-UHFFFAOYSA-M sodium;4-dodecanoyloxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(=O)C(S(O)(=O)=O)CC([O-])=O ZSSZUMCXBONOBH-UHFFFAOYSA-M 0.000 description 1
- 239000011949 solid catalyst Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 150000003754 zirconium Chemical class 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、殺菌性化合物の滞
留性が向上された殺菌性化合物含有組成物に関し、より
詳しくは、殺菌性化合物の毛髪や皮膚等への滞留性に優
れるのみならず、使用性にも優れ、且つマイルドで保存
安定性が良好であって、毛髪用組成物、皮膚外用組成物
等として好適に使用されると共に、更に、良好な泡立ち
や泡感触を得ることも可能であり、特に毛髪用洗浄剤や
皮膚用洗浄剤等の身体用洗浄剤組成物としても好適な殺
菌性化合物含有組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a bactericidal compound-containing composition having an improved germicidal compound retention property, and more particularly, not only to a bactericidal compound having excellent retention properties on hair, skin, etc. It has excellent usability, is mild and has good storage stability, and is suitable for use as a composition for hair and a composition for external use on the skin. In addition, it is possible to obtain good foaming and foam feeling. In particular, the present invention relates to a bactericidal compound-containing composition suitable as a body cleaning composition such as a hair cleaning agent and a skin cleaning agent.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】従来、
毛髪又は皮膚に使用する殺菌効果を有する化合物を配合
した組成物において、殺菌効果を有する化合物の効果を
最大限に発揮する工夫がなされてきた。例えばシャンプ
ーやボディーソープなどの洗浄剤組成物では、洗い流し
たときに毛髪や皮膚への殺菌成分(殺菌性化合物)の滞
留性を高める処方として、すすぎ後に毛髪や皮膚に膜の
形成性を有する高分子化合物等を組成物中に配合するこ
とが行われていた。2. Description of the Related Art
In a composition containing a compound having a bactericidal effect used for hair or skin, a device for maximizing the effect of the compound having a bactericidal effect has been devised. For example, in a cleaning composition such as shampoo or body soap, as a prescription for enhancing the retention of bactericidal components (bactericidal compounds) on hair and skin when washed away, a high-grade composition having a film-forming property on hair and skin after rinsing. It has been practiced to incorporate a molecular compound or the like into a composition.
【0003】また、にきびを防ぐために、皮膚を清浄に
する目的の洗顔剤においても、殺菌性化合物の皮膚への
残留性を低下させる洗浄基剤の配合量を必要最低量に抑
制するなどの工夫がなされていたが、このような工夫は
処方を組む上で殺菌効果以外の性能についての自由度を
低下させる要因となっていた。[0003] Further, in order to prevent acne, even in a facial cleanser intended to cleanse the skin, the amount of a cleaning base that reduces the persistence of the bactericidal compound on the skin is reduced to a minimum amount. However, such ingenuity has been a factor in reducing the degree of freedom regarding performance other than the bactericidal effect in formulating a prescription.
【0004】特にシャンプーなどの毛髪用洗浄剤の場
合、好適に使用される洗浄基剤としては、アニオン活性
剤であるポリオキシエチレンアルキルエーテル硫酸塩
(AES)などが挙げられるが、従来のAESは、ポリ
オキシエチレンの付加モル数の分布が広いために、本来
特定の付加モル数のAESにおいて発揮される特定の性
能を発現するためには、実質的にAESそのものや併用
添加剤を必要量より過剰に使用せざるを得ないという欠
点を有していた。[0004] Particularly in the case of a hair cleansing agent such as a shampoo, a suitable washing base includes polyoxyethylene alkyl ether sulfate (AES), which is an anionic activator. Because the distribution of the number of moles of polyoxyethylene added is wide, the AES itself or the additive additive is required to be substantially smaller than the required amount in order to exhibit the specific performance originally exhibited in the AES having the specific number of moles added. It had the disadvantage that it had to be used in excess.
【0005】即ち、一般に従来から洗浄剤などに工業的
に使用されているAESは、親水部のオキシエチレン鎖
長に幅広い分布を有している。そのため、例えばエチレ
ンオキシドの付加モル数が3モルのAESを選定した場
合、洗浄力及び泡性能の面で好適なエチレンオキシド付
加モル数1〜6のものは、約63質量%含有されるが、
その一方で、洗浄力が高く、且つマイルド性及び高分子
化合物との膜形成性の低いエチレンオキシド付加モル数
0のアルキルサルフェートの含有量が約13質量%にま
で増加するために、得られる洗浄剤組成物は、AESの
配合量と比較して膜形成性が不充分であったり、洗浄力
が強すぎて殺菌性化合物等の配合成分が洗い流されやす
かったりするために、処方中の殺菌効果を有する化合物
の毛髪や皮膚への滞留性に劣り、しかもマイルド性が不
充分なものになってしまっていた。[0005] That is, AES generally conventionally used industrially for cleaning agents and the like has a wide distribution of oxyethylene chain lengths in the hydrophilic portion. Therefore, for example, when AES having an addition mole number of ethylene oxide of 3 moles is selected, about 63% by mass of ethylene oxide addition mole number 1 to 6, which is preferable in terms of detergency and foam performance,
On the other hand, since the content of the alkyl sulfate having no ethylene oxide addition mole number of 0 having a high detergency and a low mildness and a low film-forming property with a polymer compound is increased to about 13% by mass, the resulting detergent is obtained. Since the composition has insufficient film-forming property as compared with the amount of AES, or has too strong a detergency, and the components such as bactericidal compounds are easily washed off, the bactericidal effect during the formulation is reduced. The compound has poor retentivity to hair and skin and has insufficient mildness.
【0006】一方、マイルド性や殺菌性化合物の毛髪、
皮膚等への滞留性、使用性を考慮して、エチレンオキシ
ド付加モル数が5モルのAESを選定した場合、泡性能
が良好でマイルド性、保存安定性の面でも好適なエチレ
ンオキシド付加モル数が1〜6モルのアルキルエトキシ
サルフェートは、実際には約45%しか含有されておら
ず、残りの大部分は洗浄の目的や組成物に使用しやすい
粘性を持たせるにはほとんど寄与しない構造のものであ
り、これらを満足させるためにAESの配合量を増やす
と、経済的にも好ましくなかった。On the other hand, hair of mild or bactericidal compounds,
When AES having an ethylene oxide addition mole number of 5 mol is selected in consideration of the retention property on the skin and the usability, the ethylene oxide addition mole number which is favorable in terms of foam performance, mildness and storage stability is 1 66 moles of alkyl ethoxy sulphate actually contains only about 45%, most of which are of a structure that contributes little to the purpose of cleaning or to have a viscosity that is easy to use in the composition. However, if the amount of AES was increased to satisfy these requirements, it was not economically preferable.
【0007】本発明は、上記事情に鑑みてなされたもの
で、殺菌性化合物の毛髪や皮膚等への滞留性を向上させ
ることができるのみならず、毛髪や皮膚等に適用する際
に、使用しやすく、且つマイルドで保存安定性が良好で
あり、毛髪用組成物又は皮膚外用組成物等として好適に
使用することができ、更に、泡立ちや泡感触も良好にす
ることが可能であり、特に毛髪用洗浄剤、皮膚用洗浄剤
等の身体用洗浄剤組成物として好適な殺菌性化合物含有
組成物を提供することを目的とする。The present invention has been made in view of the above circumstances, and not only can improve the retention of a bactericidal compound on hair, skin, etc., but also can be used when applied to hair, skin, etc. It is easy to use, mild and has good storage stability, and can be suitably used as a composition for hair or a composition for external use on the skin. An object of the present invention is to provide a bactericidal compound-containing composition suitable as a body cleaning composition such as a hair cleaning agent and a skin cleaning agent.
【0008】[0008]
【課題を解決するための手段及び発明の実施の形態】本
発明者は、上記目的を達成するため鋭意検討した結果、
下記一般式(1)で示されるエチレンオキシド付加モル
数の分布の幅が狭い特定のアルキルエトキシサルフェー
ト及び/又はその塩に着目するに至り、更に鋭意検討し
た結果、後述する実施例に示すように、この特定のアル
キルエトキシサルフェート及び/又はその塩を殺菌効果
を有する殺菌性化合物と併用すると共に、組成物の粘度
を所定範囲に調整することによって、上記殺菌性化合物
の毛髪や皮膚等への滞留性を向上させることができるの
みならず、毛髪や皮膚等に適用する際の使用性に優れ、
且つマイルドで保存安定性も良好な組成物が得られ、更
に、良好な泡立ちや泡性能を得ることも可能となること
を知見した。Means for Solving the Problems and Embodiments of the Invention As a result of intensive studies to achieve the above object, the present inventor has found that
Attention has been paid to a specific alkyl ethoxy sulfate and / or a salt thereof having a narrow distribution width of the ethylene oxide addition mole number represented by the following general formula (1), and as a result of further intensive studies, as shown in Examples described later, By using this specific alkyl ethoxy sulfate and / or its salt in combination with a bactericidal compound having a bactericidal effect and adjusting the viscosity of the composition to a predetermined range, the retention of the bactericidal compound on hair, skin, etc. Not only can be improved, but also have excellent usability when applied to hair, skin, etc.
In addition, it has been found that a composition which is mild and has good storage stability can be obtained, and further, good foaming and foaming performance can be obtained.
【0009】 R1O−(CH2CH2O)n−SO3M …(1) (但し、上記式中、R1は、炭素数6〜24の直鎖状又
は分岐鎖状のアルキル基又はアルケニル基であり、n
は、エチレンオキシド基の平均付加モル数を示し、1〜
6の範囲であり、Mは、水素原子、アルカリ金属、アル
カリ土類金属、アルカノールアミン又はアンモニウムで
ある。)R 1 O— (CH 2 CH 2 O) n —SO 3 M (1) (wherein, R 1 is a linear or branched alkyl group having 6 to 24 carbon atoms) Or an alkenyl group, and n
Represents the average number of moles of ethylene oxide group added,
6, and M is a hydrogen atom, an alkali metal, an alkaline earth metal, an alkanolamine or ammonium. )
【0010】即ち、特に近年では、ポリオキシエチレン
の付加モル数の分布が広いという欠点を克服したAES
の開発や、その応用が研究されるようになってきてお
り、特開平4−72395号公報に示されているような
分布の狭いAESを利用する方法が提案されるようにな
ってきたのである。上述したように、本発明者は、上記
目的を達成するために、この分布の狭いアルキルエトキ
シサルフェートに着目するに至り、このアルキルエトキ
シサルフェートについて鋭意検討した結果、エチレンオ
キシド付加モル数1〜6の範囲のアルキルエトキシサル
フェートの場合、エチレンオキシド5モル付加品の場合
でも、5モル付加のものが全体の80%近く含有され、
エチレンオキシド3モル付加品の場合は、3モル付加の
ものが全体の約90%以上、エチレンオキシド2モル付
加品の場合は2モル付加のものが90%近く含有され、
その一方で、エチレンオキシド付加モル数が0のアルキ
ルサルフェートの含有量は、エチレンオキシド2モル付
加品の場合でも全体の10%強と少ないことから、マイ
ルド性及び保存安定性の面で有利であるのみならず、組
成物の性能を自由に調整する主基剤として非常に好適で
あることを知見し、この特定のアルキルエトキシサルフ
ェートを殺菌性化合物と併用し、更に、組成物の粘度を
所定範囲にすることによって、上記目的を達成できるこ
とを見出し、本発明をなすに至った。That is, in particular, in recent years, AES has overcome the disadvantage that the distribution of the number of moles of polyoxyethylene added is wide.
The development and application of the AES have been studied, and a method using AES having a narrow distribution as shown in Japanese Patent Application Laid-Open No. 4-72395 has been proposed. . As described above, in order to achieve the above object, the present inventor has come to pay attention to alkyl ethoxy sulfate having a narrow distribution, and as a result of earnestly studying this alkyl ethoxy sulfate, the ethylene oxide addition mole number of 1 to 6 In the case of the alkyl ethoxy sulfate of the present invention, even in the case of the ethylene oxide 5 mol addition product, the 5 mol addition product is contained in almost 80% of the whole,
In the case of the ethylene oxide 3 mole addition product, the 3 mole addition product contains about 90% or more of the whole, and in the case of the ethylene oxide 2 mole addition product, the 2 mole addition product contains nearly 90%,
On the other hand, the content of the alkyl sulfate having 0 moles of ethylene oxide added is as little as 10% or more of the total amount even in the case of 2 moles of ethylene oxide, which is advantageous only in terms of mildness and storage stability. Without finding that it is very suitable as a main base that freely adjusts the performance of the composition, using this specific alkyl ethoxy sulfate in combination with a bactericidal compound, and further adjusting the viscosity of the composition to a predetermined range As a result, they have found that the above object can be achieved, and have accomplished the present invention.
【0011】従って、本発明は、a)下記一般式(1)
で表され、異なるエチレンオキシド付加モル数のものを
含み、エチレンオキシド付加モル数が0のものが占める
質量%が最大値を示すことがなく、最大値を示すエチレ
ンオキシド付加体の質量%が15〜35であり、この前
後の付加モル数を有するエチレンオキシド付加体との総
量が55〜75質量%であるアルキルエトキシサルフェ
ート及び/又はその塩と、b)殺菌性化合物とを含有
し、25℃における粘度が10mPa・s以上であるこ
とを特徴とする殺菌性化合物含有組成物を提供する。Accordingly, the present invention provides a) the following general formula (1):
Wherein the mass% occupied by those having a different ethylene oxide addition mole number and having 0 ethylene oxide addition mole number does not show the maximum value, and the mass% of the ethylene oxide adduct showing the maximum value is 15 to 35. Containing an alkyl ethoxy sulfate and / or a salt thereof having a total amount of 55 to 75% by mass with an ethylene oxide adduct having an addition mole number before and after this, and b) a bactericidal compound, and having a viscosity at 25 ° C. of 10 mPa. -A bactericidal compound-containing composition characterized by being at least s.
【0012】 R1O−(CH2CH2O)n−SO3M …(1) (但し、上記式中、R1は、炭素数6〜24の直鎖状又
は分岐鎖状のアルキル基又はアルケニル基であり、n
は、エチレンオキシド基の平均付加モル数を示し、1〜
6の範囲であり、Mは、水素原子、アルカリ金属、アル
カリ土類金属、アルカノールアミン又はアンモニウムで
ある。)R 1 O— (CH 2 CH 2 O) n —SO 3 M (1) (wherein, R 1 is a linear or branched alkyl group having 6 to 24 carbon atoms) Or an alkenyl group, and n
Represents the average number of moles of ethylene oxide group added,
6, and M is a hydrogen atom, an alkali metal, an alkaline earth metal, an alkanolamine or ammonium. )
【0013】ここで、上記b)成分が、1−ヒドロキシ
−2−ピリドン系化合物、サリチル酸及びその塩、ピリ
チオン亜鉛類、トリクロロカルバニリド、トリクロサ
ン、塩化ベンザルコニウム、塩酸アルキルジアミノエチ
ルグリシン、メチルクロロイソチアゾリン・メチルイソ
チアゾリン系殺菌剤及びイオウから選ばれる1種又は2
種以上の殺菌性化合物であると、より好適であり、更
に、上記殺菌性化合物含有組成物が、毛髪用組成物又は
皮膚外用組成物であれば、特に好適である。Here, the component (b) is a 1-hydroxy-2-pyridone compound, salicylic acid and its salts, zinc pyrithione, trichlorocarbanilide, triclosan, benzalkonium chloride, alkyldiaminoethylglycine hydrochloride, methyl One or two selected from chloroisothiazoline / methylisothiazoline fungicides and sulfur
More than one kind of fungicidal compound is more preferable, and it is particularly preferable that the composition containing a fungicidal compound is a composition for hair or a composition for external use on skin.
【0014】以下、本発明を更に詳細に説明する。本発
明の殺菌性化合物含有組成物は、上述したように、a)
上記一般式(1)で表されるアルキルエトキシサルフェ
ート及び/又はその塩と、b)殺菌性化合物とを含有
し、25℃における粘度が10mPa・s以上のもので
ある。Hereinafter, the present invention will be described in more detail. The fungicidal compound-containing composition of the present invention comprises, as described above, a)
It contains an alkylethoxy sulfate and / or a salt thereof represented by the general formula (1) and b) a bactericidal compound, and has a viscosity at 25 ° C. of 10 mPa · s or more.
【0015】ここで、本発明のa)成分であるアルキル
エトキシサルフェート及びその塩は、一般式R1O−
(CH2CH2O)n−SO3M…(1)で表わされ、式
中、R1は、炭素数6〜24、好ましくは10〜18の
直鎖状又は分岐鎖状のアルキル基又はアルケニル基であ
る。炭素数が6未満の場合は、充分な泡性能が得られな
い。また、炭素数が24を超える場合は、活性剤自体の
溶解度が減少するため保存時に析出が生じやすい。Here, the alkyl ethoxy sulfate and its salt, which are the component a) of the present invention, have the general formula R 1 O-
(CH 2 CH 2 O) n —SO 3 M (1) wherein R 1 is a linear or branched alkyl group having 6 to 24, preferably 10 to 18 carbon atoms. Or an alkenyl group. If the number of carbon atoms is less than 6, sufficient foam performance cannot be obtained. On the other hand, when the number of carbon atoms exceeds 24, the solubility of the activator itself decreases, so that precipitation tends to occur during storage.
【0016】具体的に好ましいアルキル基又はアルケニ
ル基を例示すると、ヘキシル基、オクチル基、デシル
基、ドデシル基、ミリスチル基、パルミチル基、ステア
リル基、オレイル基、アラキル基、ベヘニル基等を挙げ
ることができるが、本発明のアルキルエトキシサルフェ
ートはこれらに限定されるものではない。Specific examples of preferred alkyl or alkenyl groups include hexyl, octyl, decyl, dodecyl, myristyl, palmityl, stearyl, oleyl, aralkyl, and behenyl. Although it is possible, the alkyl ethoxy sulfate of the present invention is not limited to these.
【0017】本発明の場合、これらのアルキル基又はア
ルケニル基が1種単独のものであっても、又は2種以上
を混合したものであってもよく、更に、これらは天然原
料から入手できる直鎖アルキル基や分岐アルキル基、又
はこれらに対応するアルケニル基であっても、合成され
たものでも良い。例えば、市販されているドバノック
ス、ドバノール、ダイアドール、ネオドール等の合成ア
ルコールや椰子油高級アルコール等の天然アルコールは
原料として非常に好適に使用することができる。In the case of the present invention, these alkyl groups or alkenyl groups may be used alone or as a mixture of two or more kinds. It may be a chain alkyl group or a branched alkyl group, or an alkenyl group corresponding thereto, or may be a synthesized one. For example, commercially available synthetic alcohols such as dovanox, dovanol, diadol and neodol, and natural alcohols such as coconut oil higher alcohols can be very suitably used as raw materials.
【0018】また、上記一般式(1)において、nはエ
チレンオキシド基の平均付加モル数を示し、1〜6の範
囲、より好ましくは1.5〜4、更に好ましくは2〜3
の範囲である。nが1未満であるとエチレンオキシド付
加モル数が0のアルキルサルフェート含有量が多くなり
すぎ、洗浄力が強すぎたり、例えばカチオン性の高分子
化合物との作用により生成する複合体などからなる膜の
形成性を妨げたりするため、殺菌性化合物の毛髪や皮膚
等への滞留性が低下されたり、マイルド性及び保存安定
性が満足できなくなる。また逆に、nが6を超えて大き
い場合は、例えば泡性能を満足することができない等の
問題が生じるのみならず、組成物の粘度を上昇させる効
果が小さく、本発明の組成物の粘度を上記所定範囲に調
整するために、a)成分とは別に組成物に増粘効果のあ
る成分を添加あるいは増量する必要が生じてしまう等の
製剤設計上の制限が生じる。In the above general formula (1), n represents the average number of moles of ethylene oxide group added, and is in the range of 1 to 6, more preferably 1.5 to 4, and still more preferably 2 to 3.
Range. When n is less than 1, the content of the alkyl sulfate having the ethylene oxide addition mole number of 0 is too large, the detergency is too strong, and for example, a film composed of a complex formed by the action with a cationic polymer compound is used. Since the formation property is hindered, the retentivity of the bactericidal compound on hair, skin, and the like is reduced, and the mildness and storage stability cannot be satisfied. On the contrary, when n is larger than 6, not only a problem such as inability to satisfy the foaming performance occurs, but also the effect of increasing the viscosity of the composition is small, and the viscosity of the composition of the present invention is small. In order to adjust to within the above-mentioned predetermined range, there is a restriction on the formulation design such as the necessity of adding or increasing the component having a thickening effect to the composition separately from the component a).
【0019】更にまた、上記一般式(1)で表わされる
アルキルエトキシサルフェート又はその塩におけるMは
対イオンであり、水素原子、ナトリウム,カリウム等の
アルカリ金属、アルカリ土類金属、モノエタノールアミ
ン,ジエタノールアミン,トリエタノールアミン,イソ
プロパノールアミン等のアルカノールアミン又はアンモ
ニウムから誘導されるカチオン基である。Further, M in the alkyl ethoxy sulfate or a salt thereof represented by the general formula (1) is a counter ion, and is a hydrogen atom, an alkali metal such as sodium or potassium, an alkaline earth metal, monoethanolamine, diethanolamine. Cation groups derived from alkanolamines or ammonium such as triethanolamine, isopropanolamine, etc.
【0020】また、本発明のa)成分であるアルキルエ
トキシサルフェートは、異なるエチレンオキシド付加モ
ル数のものを含む、即ち、エチレンオキシド付加モル数
の分布を有するアルキルエトキシサルフェートであり、
以下に詳述する特徴を有するエチレンオキシド付加モル
数の分布が狭いものである。The alkyl ethoxy sulfate which is the component a) of the present invention includes those having different moles of ethylene oxide added, that is, alkyl ethoxy sulfates having a distribution of moles of ethylene oxide added,
It has a narrow distribution of the number of moles of ethylene oxide added, which has the characteristics described below in detail.
【0021】まず、上記分布において、エチレンオキシ
ド付加モル数が0のものが占める質量%が最大値を示す
ことがない。即ち、マイルド性及び保存安定性にデメリ
ットを有するアルキルサルフェートが最も多く含まれる
ものではないことを特徴とする。First, in the above distribution, the mass% occupied by the case where the ethylene oxide addition mole number is 0 does not show the maximum value. That is, it is characterized in that the alkyl sulfate having disadvantages in mildness and storage stability is not most contained.
【0022】また、上記分布において最大値を示すエチ
レンオキシド付加体の全アルキルエトキシサルフェート
に対する割合が15〜35質量%、好ましくは20〜3
0質量%であり、且つこのエチレンオキシド付加体と、
その前後の付加モル数、即ち、例えば該エチレンオキシ
ド付加体のエチレンオキシド付加モル数がPであれば、
P±1の付加モル数を有するエチレンオキシド付加体と
の総量が55〜75質量%、好ましくは60〜70質量
%である分布の狭いアルキルエトキシサルフェート及び
その塩であるということを特徴とする。The ratio of the ethylene oxide adduct having the maximum value in the above distribution to the total alkyl ethoxy sulfate is 15 to 35% by mass, preferably 20 to 3% by mass.
0% by mass, and the ethylene oxide adduct,
If the addition mole number before and after that, that is, for example, the ethylene oxide addition mole number of the ethylene oxide adduct is P,
It is characterized by a narrow distribution of alkyl ethoxy sulfate and a salt thereof having a total amount of an ethylene oxide adduct having an addition mole number of P ± 1 of 55 to 75% by mass, preferably 60 to 70% by mass.
【0023】これらの特徴を言い換えれば、本発明のア
ルキルエトキシサルフェートは、殺菌性化合物含有組成
物の主基剤、特に毛髪用組成物及び皮膚外用組成物の主
基剤として好適な構造のものに集約された、いわば精製
されたアルキルエトキシサルフェートである。In other words, the alkyl ethoxy sulfate of the present invention has a structure suitable as a main base of a composition containing a bactericidal compound, particularly a main base of a composition for hair and a composition for external use on the skin. It is an aggregated, so-called purified alkyl ethoxy sulfate.
【0024】本発明のa)成分であるアルキルエトキシ
サルフェート又はその塩は、上記の特徴を満たすもので
あれば、それ以外の要素で特に限定されるものではな
く、例えば製造方法も特に限定はされず、特開平1−1
64437号公報等に示されているような特定のルイス
酸固体触媒を用いて製造したものでも良いし、硫酸等の
酸性液体触媒存在下で製造したものでも良いし、一般に
工業的に行われている水酸化ナトリウム等のアルカリ触
媒存在下で、まず、分布の広いものを合成し、これを蒸
留などによって精製することにより製造したものであっ
ても良い。The alkyl ethoxy sulfate or its salt, which is the component a) of the present invention, is not particularly limited by other elements as long as it satisfies the above-mentioned characteristics. For example, the production method is also not particularly limited. And JP-A 1-1
It may be manufactured using a specific Lewis acid solid catalyst as disclosed in Japanese Patent No. 64437 or the like, may be manufactured in the presence of an acidic liquid catalyst such as sulfuric acid, or may be generally used industrially. In the presence of an alkali catalyst such as sodium hydroxide or the like, a compound having a broad distribution may be first synthesized and purified by distillation or the like.
【0025】本発明の組成物における上記a)成分の配
合量は、特に制限されるものではないが、1種を単独で
使用して、又は2種以上を適宜組み合わせて使用する場
合、通常組成物全体に対して5〜25%(質量%、以下
同様)、特に6〜20%とすると好適である。配合量が
5%未満であると、組成物の主基剤としては泡立ちが不
足気味になり、泡感触も水っぽくなって、使用時に充分
な満足感が得られない場合がある。また、配合量が25
%を超えて多い場合は、殺菌性化合物の滞留性を著しく
妨げたり、組成物のマイルド性を低下させる場合があ
り、さらに組成物の低温での保存安定性が保たれない場
合がある。The amount of the component (a) in the composition of the present invention is not particularly limited, but when one type is used alone or two or more types are used in combination as appropriate, The content is preferably 5 to 25% (mass%, the same applies hereinafter), particularly 6 to 20%, based on the whole product. If the amount is less than 5%, the foaming of the main base of the composition tends to be insufficient, and the foam feel becomes watery, so that sufficient satisfaction may not be obtained during use. In addition, the compounding amount is 25
When the amount is more than%, the retention of the bactericidal compound may be significantly impaired, the mildness of the composition may be reduced, and the storage stability of the composition at low temperatures may not be maintained.
【0026】本発明の第2の必須成分であるb)成分
は、通常、香粧品組成物等に使用され、毛髪や皮膚等に
対して殺菌効果を付与する化合物であれば、いずれのも
のも使用することができる。The component (b), which is the second essential component of the present invention, is usually used in cosmetic compositions and the like, and any compound that imparts a bactericidal effect to hair, skin and the like can be used. Can be used.
【0027】このような化合物としては、例えば1−ヒ
ドロキシ−2−ピリドン系化合物、サリチル酸及びその
塩、ピリチオン亜鉛類、トリクロロカルバニリド、トリ
クロサン、塩化ベンザルコニウム、塩酸アルキルジアミ
ノエチルグリシン、メチルクロロイソチアゾリン・メチ
ルイソチアゾリン系殺菌剤及びイオウ等を挙げることが
でき、これらは1種単独で又は2種以上を適宜組み合わ
せて使用することができる。なお、メチルクロロイソチ
アゾリン・メチルイソチアゾリン系殺菌剤は、5−クロ
ロ−2−メチル−4−イソチアゾリン−3−オンと2−
メチル−4−イソチアゾリン−3−オンとの混合物であ
る。本発明の場合、これらの中でも特に下記一般式
(2)で表される1−ヒドロキシ−2−ピリドン系化合
物が特に好適に使用される。Examples of such compounds include 1-hydroxy-2-pyridone compounds, salicylic acid and salts thereof, zinc pyrithione, trichlorocarbanilide, triclosan, benzalkonium chloride, alkyldiaminoethylglycine hydrochloride, methylchloroform An isothiazoline / methyl isothiazoline fungicide and sulfur can be mentioned, and these can be used alone or in an appropriate combination of two or more. The methylchloroisothiazoline / methylisothiazoline fungicides are 5-chloro-2-methyl-4-isothiazolin-3-one and 2-
It is a mixture with methyl-4-isothiazolin-3-one. In the case of the present invention, among these, a 1-hydroxy-2-pyridone-based compound represented by the following general formula (2) is particularly preferably used.
【0028】[0028]
【化1】 Embedded image
【0029】(但し、上記式中、R2は、1〜17個の
炭素原子を有するアルキル基、2〜17個の炭素原子を
有するアルケニル基、5〜8個の炭素原子を有するシク
ロアルキル基、7〜9個の炭素原子を有するビシクロア
ルキル基、シクロアルキル基が5〜8個の炭素原子を有
し、且つアルキル基が1〜4個の炭素原子を有するシク
ロアルキル−アルキル基(但し、シクロアルキル基は、
その水素原子の一部が炭素数1〜4のアルキル基によっ
て置換されていてもよい)、6〜14個の炭素原子を有
するアリール基、アリール基が6〜14個の炭素原子を
有し、且つアルキル基が1〜4個の炭素原子を有するア
ラルキル基、アリール基が6〜14個の炭素原子を有
し、且つアルケニル基が2〜4個の炭素原子を有するア
リールアルケニル基、アリール基が6〜14個の炭素原
子を有し、且つアルキル基がそれぞれ1〜4個の炭素原
子を有するアリールオキシアルキル基もしくはアリール
メルカプトアルキル基、ベンズヒドリル基、アルキル基
が1〜4個の炭素原子を有するフェニルスルホニルアル
キル基、フリル基又はアルケニル基が2〜4個の炭素原
子を有するフリルアルケニル基を表す。但し、上述のア
リール基は、その水素原子の一部が1〜4個の炭素原子
を有するアルキル基、1〜4個の炭素原子を有するアル
コキシ基、ニトロ基、シアノ基又はハロゲン原子によっ
て置換されていてもよい。R3は、水素原子、1〜4個
の炭素原子を有するアルキル基、2〜4個の炭素原子を
有するアルケニル基、2〜4個の炭素原子を有するアル
キニル基、ハロゲン原子、フェニル基又はベンジル基を
表す。Xは、有機塩基、アルカリ金属イオン、アンモニ
ウムイオン又は2〜4価の陽イオンを表す。)(Wherein R 2 is an alkyl group having 1 to 17 carbon atoms, an alkenyl group having 2 to 17 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms) A cycloalkyl-alkyl group having from 7 to 9 carbon atoms, a cycloalkyl group having from 5 to 8 carbon atoms, and an alkyl group having from 1 to 4 carbon atoms (provided that A cycloalkyl group is
A part of the hydrogen atoms may be substituted by an alkyl group having 1 to 4 carbon atoms), an aryl group having 6 to 14 carbon atoms, and the aryl group having 6 to 14 carbon atoms; Wherein the alkyl group is an aralkyl group having 1 to 4 carbon atoms, the aryl group is an arylalkenyl group having 6 to 14 carbon atoms, and the alkenyl group is an arylalkenyl group having 2 to 4 carbon atoms. An aryloxyalkyl or arylmercaptoalkyl group having from 6 to 14 carbon atoms and an alkyl group each having from 1 to 4 carbon atoms, a benzhydryl group, an alkyl group having from 1 to 4 carbon atoms A phenylsulfonylalkyl group, a furyl group or an alkenyl group represents a furylalkenyl group having 2 to 4 carbon atoms. However, in the above-mentioned aryl group, a part of the hydrogen atoms is substituted by an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a nitro group, a cyano group or a halogen atom. May be. R 3 represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, an alkynyl group having 2 to 4 carbon atoms, a halogen atom, a phenyl group or benzyl. Represents a group. X represents an organic base, an alkali metal ion, an ammonium ion or a divalent to tetravalent cation. )
【0030】上記一般式(2)で表される化合物の具体
例としては、例えば下記化合物及びその塩などを挙げる
ことができる。Specific examples of the compound represented by the general formula (2) include the following compounds and salts thereof.
【0031】1−ヒドロキシ−2−ピリドン、1−ヒド
ロキシ−4−メチル−2−ピリドン、1−ヒドロキシ−
6−メチル−2−ピリドン、1−ヒドロキシ−4,6−
ジメチル−2−ピリドン、1−ヒドロキシ−4−メチル
−6−ヘプチル−2−ピリドン、1−ヒドロキシ−4−
メチル−6−(1−エチルペンチル)−2−ピリドン、
1−ヒドロキシ−4−メチル−6−(2,4,4−トリ
メチルペンチル)−2−ピリドン、1−ヒドロキシ−4
−メチル−6−ウンデシル−2−ピリドン、1−ヒドロ
キシ−4−メチル−6−プロペニル−2−ピリドン、1
−ヒドロキシ−4−メチル−6−オクテニル−2−ピリ
ドン、1−ヒドロキシ−4−メチル−6−(2,2−ジ
ブチル−ビニル)−2−ピリドン、1−ヒドロキシ−4
−メチル−6−(シクロヘキセニリデン−メチル)−2
−ピリドン、1−ヒドロキシ−4−メチル−6−シクロ
ヘキシル−2−ピリドン、1−ヒドロキシ−4−メチル
−6−(メチル−シクロヘキシル)−2−ピリドン、1
−ヒドロキシ−4−メチル−6−(2−ビシクロ〔2,
2,1〕ヘプチル)−2−ピリドン、1−ヒドロキシ−
4−メチル−6−〔2−(ジメチルシクロヘキシル)−
プロピル〕−2−ピリドン、1−ヒドロキシ−4−メチ
ル−6−(4−メチル−フェニル)−2−ピリドン、1
−ヒドロキシ−4―メチル−6−(3−メチル−フェニ
ル)−2−ピリドン、1−ヒドロキシ−4−メチル−6
−(4−第3ブチル−フェニル)−2−ピリドン、1−
ヒドロキシ−4−メチル−6−(3−メチル−4−クロ
ル−フェニル)−2−ピリドン、1−ヒドロキシ−4−
メチル−6−(3,5−ジクロル−フェニル)−2−ピ
リドン、1−ヒドロキシ−4−メチル−6−(3−ブロ
ム−4−クロル−フェニル)−2−ピリドン、1−ヒド
ロキシ−4−メチル−6−(4−メトキシスチリル)−
2−ピリドン、1−ヒドロキシ−4−メチル−6−〔1
−(4−ニトロフェノキシ)−ブチル〕−2−ピリド
ン、1−ヒドロキシ−4−メチル−6−(4−シアノフ
ェノキシメチル)−2−ピリドン、1−ヒドロキシ−4
−メチル−6−(フェニルスルホニルメチル)−2−ピ
リドン、1−ヒドロキシ−4−メチル−6−〔1−(4
−クロルフェニルスルホニル)−ブチル〕−2−ピリド
ン、1−ヒドロキシ−4−メチル−6−ベンジル−2−
ピリドン、1−ヒドロキシ−4−メチル−6−(2,4
−ジメチルベンジル)−2−ピリドン、1−ヒドロキシ
−4−メチル−6−(第3ブチル−ベンジル)−2−ピ
リドン、1−ヒドロキシ−4−メチル−6−(2−クロ
ル−ベンジル)−2−ピリドン、1−ヒドロキシ−4−
メチル−6−(4−クロルベンジル)−2−ピリドン、
1−ヒドロキシ−4−メチル−6−(2,5−ジクロル
−ベンジル)−2−ピリドン、1−ヒドロキシ−4−メ
チル−6−(4−ブロム−ベンジル)−2−ピリドン、
1−ヒドロキシ−4−メチル−6−(フェノキシメチ
ル)−2−ピリドン、1−ヒドロキシ−4−メチル−6
−(3−メチルフェノキシ−メチル)−2−ピリドン、
1−ヒドロキシ−4−メチル−6−(4−第2ブチルフ
ェノキシ−メチル)−2−ピリドン、1−ヒドロキシ−
4−メチル−6−(2,4,5−トリクロルフェノキシ
−メチル)−2−ピリドン、1−ヒドロキシ−4−メチ
ル−6−(4−ブロムフェノキシ−メチル)−2−ピリ
ドン、1−ヒドロキシ−4−メチル−6−(4−クロル
フェニルメルカプト−メチル)−2−ピリドン、1−ヒ
ドロキシ−4−メチル−6−(4−メチルフェニルメル
カプト−メチル)−2−ピリドン、1−ヒドロキシ−4
−メチル−6−(2−ナフチル)−2−ピリドン、1−
ヒドロキシ−4−メチル−6−ベンズヒドリル−2−ピ
リドン、1−ヒドロキシ−4−メチル−6−フリル−2
−ピリドン、1−ヒドロキシ−4−メチル−6−(フリ
ルビニル)−2−ピリドン、1−ヒドロキシ−4−メチ
ル−6−スチリル−2−ピリドン、1−ヒドロキシ−4
−メチル−6−(フェニルブタジエニル)−2−ピリド
ン、1−ヒドロキシ−4−フェニル−6−メチル−2−
ピリドン、1−ヒドロキシ−4,6−ジフェニル−2−
ピリドン等を挙げることができる。1-hydroxy-2-pyridone, 1-hydroxy-4-methyl-2-pyridone, 1-hydroxy-
6-methyl-2-pyridone, 1-hydroxy-4,6-
Dimethyl-2-pyridone, 1-hydroxy-4-methyl-6-heptyl-2-pyridone, 1-hydroxy-4-
Methyl-6- (1-ethylpentyl) -2-pyridone,
1-hydroxy-4-methyl-6- (2,4,4-trimethylpentyl) -2-pyridone, 1-hydroxy-4
-Methyl-6-undecyl-2-pyridone, 1-hydroxy-4-methyl-6-propenyl-2-pyridone, 1
-Hydroxy-4-methyl-6-octenyl-2-pyridone, 1-hydroxy-4-methyl-6- (2,2-dibutyl-vinyl) -2-pyridone, 1-hydroxy-4
-Methyl-6- (cyclohexenylidene-methyl) -2
-Pyridone, 1-hydroxy-4-methyl-6-cyclohexyl-2-pyridone, 1-hydroxy-4-methyl-6- (methyl-cyclohexyl) -2-pyridone,
-Hydroxy-4-methyl-6- (2-bicyclo [2,
2,1] heptyl) -2-pyridone, 1-hydroxy-
4-methyl-6- [2- (dimethylcyclohexyl)-
Propyl] -2-pyridone, 1-hydroxy-4-methyl-6- (4-methyl-phenyl) -2-pyridone,
-Hydroxy-4-methyl-6- (3-methyl-phenyl) -2-pyridone, 1-hydroxy-4-methyl-6
-(4-tert-butyl-phenyl) -2-pyridone, 1-
Hydroxy-4-methyl-6- (3-methyl-4-chloro-phenyl) -2-pyridone, 1-hydroxy-4-
Methyl-6- (3,5-dichloro-phenyl) -2-pyridone, 1-hydroxy-4-methyl-6- (3-bromo-4-chloro-phenyl) -2-pyridone, 1-hydroxy-4- Methyl-6- (4-methoxystyryl)-
2-pyridone, 1-hydroxy-4-methyl-6- [1
-(4-nitrophenoxy) -butyl] -2-pyridone, 1-hydroxy-4-methyl-6- (4-cyanophenoxymethyl) -2-pyridone, 1-hydroxy-4
-Methyl-6- (phenylsulfonylmethyl) -2-pyridone, 1-hydroxy-4-methyl-6- [1- (4
-Chlorophenylsulfonyl) -butyl] -2-pyridone, 1-hydroxy-4-methyl-6-benzyl-2-
Pyridone, 1-hydroxy-4-methyl-6- (2,4
-Dimethylbenzyl) -2-pyridone, 1-hydroxy-4-methyl-6- (tert-butyl-benzyl) -2-pyridone, 1-hydroxy-4-methyl-6- (2-chloro-benzyl) -2 -Pyridone, 1-hydroxy-4-
Methyl-6- (4-chlorobenzyl) -2-pyridone,
1-hydroxy-4-methyl-6- (2,5-dichloro-benzyl) -2-pyridone, 1-hydroxy-4-methyl-6- (4-bromo-benzyl) -2-pyridone,
1-hydroxy-4-methyl-6- (phenoxymethyl) -2-pyridone, 1-hydroxy-4-methyl-6
-(3-methylphenoxy-methyl) -2-pyridone,
1-hydroxy-4-methyl-6- (4-secondary-butylphenoxy-methyl) -2-pyridone, 1-hydroxy-
4-methyl-6- (2,4,5-trichlorophenoxy-methyl) -2-pyridone, 1-hydroxy-4-methyl-6- (4-bromophenoxy-methyl) -2-pyridone, 1-hydroxy- 4-methyl-6- (4-chlorophenylmercapto-methyl) -2-pyridone, 1-hydroxy-4-methyl-6- (4-methylphenylmercapto-methyl) -2-pyridone, 1-hydroxy-4
-Methyl-6- (2-naphthyl) -2-pyridone, 1-
Hydroxy-4-methyl-6-benzhydryl-2-pyridone, 1-hydroxy-4-methyl-6-furyl-2
-Pyridone, 1-hydroxy-4-methyl-6- (furylvinyl) -2-pyridone, 1-hydroxy-4-methyl-6-styryl-2-pyridone, 1-hydroxy-4
-Methyl-6- (phenylbutadienyl) -2-pyridone, 1-hydroxy-4-phenyl-6-methyl-2-
Pyridone, 1-hydroxy-4,6-diphenyl-2-
Pyridone and the like can be mentioned.
【0032】上記化合物は、塩として用いられ、例えば
有機アミンとの塩として好適に使用することができる。
具体的には、例えばエタノールアミン、ジエタノールア
ミン、N−エチルエタノールアミン、N−メチル−ジエ
タノールアミン、トリエタノールアミン、ジエチルアミ
ノ−エタノール、2−アミノ−2−メチル−n−プロパ
ノール、ジメチルアミノプロパノール、2−アミノ−2
−メチル−プロパンジオール、トリ−イソプロパノール
アミン、エチレンジアミン、ヘキサメチレンジアミン、
モルホリン、ピペリジン、シクロヘキシルアミン、トリ
ブチルアミン、ドデシルアミン、N,N−ジメチル−ド
デシルアミン、ステアリルアミン、オレイルアミン、ベ
ンジルアミン、ジベンジルアミン、N−エチルベンジル
アミン、ジメチルステアリルアミン、N−メチル−モル
ホリン、N−メチルピペラジン、4−メチルシクロヘキ
シルアミン、N−ヒドロキシエチル−モルホリン等が挙
げられる。The above compound is used as a salt, and can be suitably used, for example, as a salt with an organic amine.
Specifically, for example, ethanolamine, diethanolamine, N-ethylethanolamine, N-methyl-diethanolamine, triethanolamine, diethylamino-ethanol, 2-amino-2-methyl-n-propanol, dimethylaminopropanol, 2-amino -2
-Methyl-propanediol, tri-isopropanolamine, ethylenediamine, hexamethylenediamine,
Morpholine, piperidine, cyclohexylamine, tributylamine, dodecylamine, N, N-dimethyl-dodecylamine, stearylamine, oleylamine, benzylamine, dibenzylamine, N-ethylbenzylamine, dimethylstearylamine, N-methyl-morpholine, N-methylpiperazine, 4-methylcyclohexylamine, N-hydroxyethyl-morpholine and the like can be mentioned.
【0033】また、本発明に用いられる1−ヒドロキシ
−2−ピリドン系化合物は、無機イオンとの塩であって
もよく、例えばナトリウム塩、カリウム塩等のアルカリ
金属塩、アンモニウム塩及びマグネシウム塩、カルシウ
ム塩等のアルカリ土類金属塩などを用いることができ
る。更に、亜鉛塩、アルミニウム塩、ジルコニウム塩等
の2〜4価の陽イオンとの塩も用いることができる。The 1-hydroxy-2-pyridone compound used in the present invention may be a salt with an inorganic ion, for example, an alkali metal salt such as a sodium salt and a potassium salt, an ammonium salt and a magnesium salt. Alkaline earth metal salts such as calcium salts can be used. Further, salts with divalent to tetravalent cations such as zinc salts, aluminum salts and zirconium salts can also be used.
【0034】本発明の組成物における上記b)成分の配
合量は、特に制限されるものではないが、これら化合物
の1種を単独で又は2種以上を適宜組み合わせて使用す
る場合、通常組成物全体の0.01〜3%、特に0.0
5〜2%とすることが好ましい。殺菌性化合物の配合量
が少なすぎると充分な殺菌効果が得られない場合があ
り、一方、多すぎると例えば殺菌性化合物の溶解が不充
分で、低温での保存において析出するなど、保存安定性
がよくなかったり、また、保存の過程で容器への吸着な
どにより、配合量が有効に生かされなかったりする場合
がある。The amount of the component (b) in the composition of the present invention is not particularly limited, but when one of these compounds is used alone or in an appropriate combination of two or more, the composition is usually used. 0.01 to 3% of the whole, especially 0.0
It is preferable to set it to 5 to 2%. If the compounding amount of the bactericidal compound is too small, a sufficient bactericidal effect may not be obtained.On the other hand, if the amount is too large, for example, the dissolution of the bactericidal compound is insufficient, and the composition is preserved at a low temperature. May not be good, or the compounded amount may not be used effectively due to adsorption to a container or the like during storage.
【0035】更に、本発明の組成物は、25℃で10m
Pa・s以上の粘度を有することが必要であり、好まし
くは10〜10000mPa・s、より好ましくは15
〜8000mPa・sである。粘度が低すぎると、使用
時に手にとった場合、こぼれ落ちる、あるいは例えばシ
ャンプーとして使用した場合、頭皮を流れ落ちて目に入
るなどの不具合が生じ、使い勝手が良好でなかったり、
安全上好ましくなかったりすることがある。Further, the composition of the present invention has a viscosity of 10 m at 25 ° C.
It is necessary to have a viscosity of Pa · s or more, preferably 10 to 10000 mPa · s, more preferably 15 mPa · s.
88000 mPa · s. If the viscosity is too low, if it is picked up during use, it will spill, or if it is used as a shampoo, for example, it will run down the scalp and enter the eyes, causing inconvenience,
It may not be desirable for safety.
【0036】本発明の組成物の粘度を上記範囲とするた
めには、上記a)アルキルエトキシサルフェートを配合
することによって、組成物の粘性が得られるが、更に、
目的とする粘性を得るために、必要に応じて公知の増粘
剤を併用することもでき、このような増粘剤としては、
その種類が特に制限されるものではなく、例えば脂肪酸
アルカノールアミド、アルキルエーテル、エステルなど
のノニオン類、糖系の活性剤や高分子化合物、ベタイン
類等を好適に使用することができる。In order to keep the viscosity of the composition of the present invention within the above range, the viscosity of the composition can be obtained by blending the above-mentioned a) alkyl ethoxy sulfate.
In order to obtain the desired viscosity, a known thickening agent can be used in combination as necessary, and as such a thickening agent,
The type thereof is not particularly limited, and nonionics such as fatty acid alkanolamides, alkyl ethers and esters, sugar-based activators, polymer compounds, betaines and the like can be suitably used.
【0037】また、本発明の組成物を例えば毛髪用洗浄
剤等の毛髪用組成物又は皮膚用洗浄剤等の皮膚外用組成
物として使用する場合、通常これらの洗浄剤に含有され
るアニオン界面活性剤、両性界面活性剤及び半極性界面
活性剤の中から選ばれる1種又は2種以上の界面活性剤
を本発明の効果を妨げない範囲で含有することができ、
これによって、いっそう泡立ちや泡感触、洗浄力、すす
ぎや仕上がりの感触などに優れ、マイルドで保存安定性
が良好な組成物を得ることができる。When the composition of the present invention is used as a hair composition such as a hair cleansing agent or a skin external composition such as a skin cleansing agent, the anionic surfactant usually contained in these cleansing agents is used. Agents, amphoteric surfactants and one or more surfactants selected from semipolar surfactants can be contained in a range that does not impair the effects of the present invention,
This makes it possible to obtain a composition that is more excellent in foaming and foam feeling, detergency, rinse and finish feeling, and mild and has good storage stability.
【0038】具体的には、例えばアニオン界面活性剤と
しては、従来のエチレンオキシド付加モル数分布の広い
ポリオキシエチレンアルキルエーテル硫酸塩やアルキル
硫酸塩も使用することができるが、先に述べたように、
本発明の組成物の特徴であるエチレンオキシド付加モル
数の分布の狭い上記a)成分の特徴を消去しない程度の
併用量とする必要があり、他の成分とのバランスを勘案
して決定する必要がある。この他にも、α−オレフィン
スルホン酸塩、アシルメチルタウリン塩、アミドエーテ
ル硫酸塩、エーテルカルボン酸塩、アルカンスルホン酸
塩、アミノ酸系アニオン活性剤等を挙げることができ、
これらは1種単独で又は2種以上を適宜組み合わせて使
用することができるが、特にこれらに限定されるもので
はない。なお、これらのアニオン界面活性剤を併用する
場合、これらの合計配合量は、組成物全体に対して0〜
40%程度とすることが好ましい。Specifically, as anionic surfactants, for example, conventional polyoxyethylene alkyl ether sulfates and alkyl sulfates having a wide distribution of ethylene oxide addition moles can be used. ,
The amount of the component a), which has a narrow distribution of ethylene oxide addition moles, which is a feature of the composition of the present invention, must be used in such an amount that the feature of the component a) is not erased, and must be determined in consideration of the balance with other components. is there. In addition to these, α-olefin sulfonate, acylmethyltaurine salt, amide ether sulfate, ether carboxylate, alkane sulfonate, amino acid-based anion activator, and the like,
These can be used alone or in an appropriate combination of two or more, but are not particularly limited thereto. When these anionic surfactants are used in combination, their total amount is 0 to the total composition.
It is preferred to be about 40%.
【0039】また、両性界面活性剤としては、その種類
が特に限定されるものではないが、例えばベタイン型や
イミダゾリン型、アミノカルボン酸型などの両性界面活
性剤を1種又は2種以上用いることができる。具体的に
は、アルキルベタイン、アルキルアミドプロピルベタイ
ン、スルホベタイン、イミダゾリニウムベタイン、アミ
ノカルボン酸、アミノプロピオン酸やこれらの塩などを
挙げることができる。両性界面活性剤の配含量は、通
常、組成物全体の0〜15%、特に好適には0〜6%と
することが好ましい。The type of the amphoteric surfactant is not particularly limited. For example, one or more amphoteric surfactants such as betaine type, imidazoline type and aminocarboxylic acid type may be used. Can be. Specific examples include alkyl betaine, alkylamidopropyl betaine, sulfobetaine, imidazolinium betaine, aminocarboxylic acid, aminopropionic acid, and salts thereof. Usually, the content of the amphoteric surfactant is preferably 0 to 15%, more preferably 0 to 6%, of the whole composition.
【0040】更に、半極性界面活性剤としては、その種
類が特に限定されるものではないが、例えばアミンオキ
シド型ノニオン性界面活性剤が代表的なものとして挙げ
ることができる。具体的には、ラウリルジメチルアミン
オキシドやポリオキシエチレンラウリルジメチルアミン
オキシド等を挙げることができ、これらのアミンオキシ
ドは1種単独で又は2種以上を適宜組み合わせて組成物
に配合することができる。配合量は、組成物全体の0〜
15%、好ましくは0〜6%とすると好適である。Further, the kind of the semipolar surfactant is not particularly limited, but for example, an amine oxide type nonionic surfactant can be mentioned as a typical example. Specific examples include lauryl dimethylamine oxide and polyoxyethylene lauryl dimethylamine oxide. These amine oxides can be used alone or in combination of two or more. The amount is from 0 to the total composition.
15%, preferably 0 to 6% is suitable.
【0041】本発明の組成物を毛髪用組成物又は皮膚外
用組成物として使用する場合、特に殺菌性化合物の毛髪
や皮膚への滞留性を高める目的で、膜形成性の高分子化
合物を併用することができる。このような高分子化合物
としては、例えばカチオン化セルロース,カチオン化グ
アーガムなどのカチオン性高分子化合物、ベタイン化ジ
アルキルアミノアルキル(メタ)アクリレート又はジア
ルキルアミノアルキル(メタ)アクリルアミドなどの両
性重合体やポリベタイン系などの両性高分子化合物、ア
クリル系のアニオン系高分子化合物、ヒドロキシエチル
セルロースなどの非イオン性高分子化合物等を挙げるこ
とができ、これらは1種単独で又は2種以上を適宜組み
合わせて使用することができる。When the composition of the present invention is used as a hair composition or a composition for external use on the skin, a film-forming polymer compound is used in combination with the compound, particularly for the purpose of increasing the retention of a bactericidal compound on hair or skin. be able to. Examples of such a polymer compound include cationic polymer compounds such as cationized cellulose and cationized guar gum, amphoteric polymers such as betaine-containing dialkylaminoalkyl (meth) acrylate and dialkylaminoalkyl (meth) acrylamide, and polybetaine-based polymers. And the like. An amphoteric polymer compound such as, for example, an acrylic anionic polymer compound, and a nonionic polymer compound such as hydroxyethyl cellulose can be used. These may be used alone or in combination of two or more. Can be.
【0042】本発明の組成物は、本発明の効果を妨げな
い限り、その種類や使用態様などに応じて、必要により
任意成分として、上記成分に加えて、例えば毛髪用組成
物又は皮膚外用組成物の常用成分であるカチオン性界面
活性剤や、疎水性ノニオン界面活性剤などを配合するこ
ともでき、また、固体または液体油分、高級アルコール
類、エステル油、多価アルコール、防腐剤、ハイドロト
ロープ類、無機塩、増粘剤、香料、動植物の抽出物、フ
ケ防止剤、薬効剤、乳濁剤、パール化剤、紫外線吸収
剤、紫外線散乱剤、トニック剤、pH調整剤、色素、酸
化防止剤、低級アルコール、ビタミン類、揮発性油分、
疎水性溶媒、希釈性溶媒などを含有することができる
が、これらについては特に限定されず、目的に応じた配
合がなされてよい。The composition of the present invention may be optionally added, if necessary, in addition to the above components, for example, a hair composition or a skin external composition, as long as the effects of the present invention are not hindered. It can also contain cationic surfactants, which are common components of products, hydrophobic nonionic surfactants, etc., as well as solid or liquid oils, higher alcohols, ester oils, polyhydric alcohols, preservatives, hydrotropes , Inorganic salts, thickeners, fragrances, extracts of animals and plants, anti-dandruff agents, medicinal agents, emulsifiers, pearling agents, ultraviolet absorbers, ultraviolet scattering agents, tonic agents, pH adjusters, pigments, antioxidants Agents, lower alcohols, vitamins, volatile oils,
A hydrophobic solvent, a diluting solvent and the like can be contained, but these are not particularly limited and may be blended according to the purpose.
【0043】[0043]
【発明の効果】本発明の殺菌性化合物含有組成物は、殺
菌性化合物の毛髪や皮膚等への滞留性に優れるのみなら
ず、使用性に優れ、且つマイルドで保存安定性が良好な
ものであるので、毛髪用、皮膚外用として使用する香粧
品全般、更に台所用洗浄剤等の食器用、家具用の洗浄
剤、殺菌剤などの各種用途に使用することができ、特に
毛髪用組成物又は皮膚外用組成物として有用である。ま
た、本発明の組成物は、更に、泡立ちや泡感触を良好な
ものとすることも可能であるので、毛髪用組成物又は皮
膚外用組成物の中でも特に毛髪用洗浄剤組成物、皮膚用
洗浄剤組成物のような身体用洗浄剤組成物においてその
効果を顕著に発揮するものである。The composition containing a bactericidal compound of the present invention not only has excellent retention properties of the bactericidal compound on hair and skin, but also has excellent usability, is mild and has good storage stability. Therefore, it can be used for various purposes such as hair, general cosmetics used for external use on the skin, tableware such as kitchen cleaners, cleaning agents for furniture, disinfectants, etc. It is useful as a skin external composition. Further, the composition of the present invention can further improve foaming and foam feel, and therefore, among the compositions for hair or the composition for external use on the skin, in particular, the hair cleansing composition and the skin cleansing composition. The effect is remarkably exhibited in a body cleansing composition such as a skin care composition.
【0044】[0044]
【実施例】以下、本発明の実施例及び比較例を示し、本
発明をより具体的に説明するが、本発明は下記実施例に
より限定されるものではない。なお、以下に示す%はい
ずれも質量百分率である。EXAMPLES Hereinafter, the present invention will be described more specifically by showing Examples and Comparative Examples of the present invention, but the present invention is not limited to the following Examples. The percentages shown below are all percentages by mass.
【0045】[実施例1〜6、比較例1〜3]表1に示
すa)成分(ポリオキシエチレンアルキルエーテル硫酸
ナトリウム)を用いて、表2に示す組成に従って常法に
準じて毛髪用洗浄剤及び皮膚用洗浄剤を調製し、各組成
物の泡性能と殺菌効果を有する化合物(殺菌性化合物)
の毛髪又は皮膚への残留性、マイルド性、保存安定性、
組成物の粘性を下記評価方法に従って評価した。結果を
表2に併記する。[Examples 1 to 6, Comparative Examples 1 to 3] Using the a) component (sodium polyoxyethylene alkyl ether sulfate) shown in Table 1, according to the composition shown in Table 2, washes for hair according to a conventional method. Preparations for preparations and skin cleansers, compounds with foaming performance and bactericidal effect of each composition (bactericidal compounds)
Residue on hair or skin, mildness, storage stability,
The viscosity of the composition was evaluated according to the following evaluation method. The results are also shown in Table 2.
【0046】なお、以下に表1のアルキルエトキシサル
フェートの調製方法を述べる。 <分布の狭いアルキルエトキシサルフェート:サンプル
A−1>本発明の実施例で使用した分布の狭いラウリル
エトキシサルフェートの調製は、以下の方法で実施し
た。The method for preparing the alkyl ethoxy sulfate shown in Table 1 will be described below. <Narrow Distribution Alkylethoxy Sulfate: Sample A-1> Narrow distribution lauryl ethoxy sulfate used in Examples of the present invention was prepared by the following method.
【0047】4リットル容のオートクレーブ中にラウリ
ルアルコール400g及びAl/Mg/Mn(アルミニ
ウム/マグネシウム/マンガン)で構成される複合金属
酸化物ルイス酸焼結固体触媒0.4gを仕込み、オート
クレーブ内を窒素置換し、撹拌しながら昇温した。次い
で、温度を180℃、圧力を0.3mPaに維持しなが
らエチレンオキサイド54gを導入し、反応物を得た。
次に、このようにして得たアルコールエトキシレート2
74gを撹拌装置付の500ml容フラスコにとり、窒
素置換後、液体無水硫酸(サルファン)81gを反応温
度を40℃に保ちながらゆっくりと滴下した。滴下終了
後、1時間撹拌を続け、目的とするアルキルエトキシサ
ルフェート(ラウリルエトキシサルフェート)を得た。
得られたアルキルエトキシサルフェートの性状及びオキ
シエチレン鎖長の分布は表1に示した通りであった。な
お、サンプルA−2の調製も同様の方法により行った。A 4-liter autoclave was charged with 400 g of lauryl alcohol and 0.4 g of a solid metal oxide Lewis acid sintered catalyst composed of Al / Mg / Mn (aluminum / magnesium / manganese). This was replaced and the temperature was raised while stirring. Next, while maintaining the temperature at 180 ° C. and the pressure at 0.3 mPa, 54 g of ethylene oxide was introduced to obtain a reaction product.
Next, the thus obtained alcohol ethoxylate 2
74 g was placed in a 500 ml flask equipped with a stirrer, and after purging with nitrogen, 81 g of liquid sulfuric anhydride (sulfan) was slowly added dropwise while maintaining the reaction temperature at 40 ° C. After completion of the dropwise addition, stirring was continued for 1 hour to obtain the desired alkyl ethoxy sulfate (lauryl ethoxy sulfate).
The properties and distribution of the oxyethylene chain length of the obtained alkyl ethoxy sulfate were as shown in Table 1. The preparation of sample A-2 was performed in the same manner.
【0048】<分布の広いアルキルエトキシサルフェー
ト:サンプルAES−1>また、比較例で使用した通常
の分布の広いラウリルエトキシサルフェートの調製は、
以下の方法で実施した。<Alkylethoxy Sulfate with Wide Distribution: Sample AES-1> Also, the usual preparation of lauryl ethoxy sulfate having a wide distribution used in Comparative Examples is as follows.
The following method was used.
【0049】4リットル容のオートクレーブ中にラウリ
ルアルコール400g及び水酸化カリウム触媒0.8g
を仕込み、オートクレーブ内を窒素置換し、撹拌しなが
ら昇温した。次いで、温度180℃、圧力を0.3mP
aに維持しながらエチレンオキサイド54gを導入し、
反応物を得た。次に、このようにして得たアルコールエ
トキシレート274gを撹拌装置付の500ml容のフ
ラスコにとり、窒素置換後、液体無水硫酸(サルファ
ン)81gを反応温度を40℃に保ちながらゆっくりと
滴下した。滴下終了後、1時間撹拌を続けて目的とする
アルキルエトキシサルフェート(ラウリルエトキシサル
フェート)を得た。得られたアルキルエトキシサルフェ
ートの性状及びオキシエチレン鎖長の分布は表1に示し
た通りであった。なお、サンプルAES−2の調製も同
様の方法により行った。In a 4 liter autoclave, 400 g of lauryl alcohol and 0.8 g of potassium hydroxide catalyst
Was charged, the inside of the autoclave was replaced with nitrogen, and the temperature was raised while stirring. Next, at a temperature of 180 ° C. and a pressure of 0.3 mP
While maintaining at a, 54 g of ethylene oxide is introduced,
A reaction was obtained. Next, 274 g of the alcohol ethoxylate thus obtained was placed in a 500-ml flask equipped with a stirrer, and after purging with nitrogen, 81 g of liquid sulfuric anhydride (sulfan) was slowly added dropwise while maintaining the reaction temperature at 40 ° C. After completion of the dropwise addition, stirring was continued for 1 hour to obtain the desired alkyl ethoxy sulfate (lauryl ethoxy sulfate). The properties and distribution of the oxyethylene chain length of the obtained alkyl ethoxy sulfate were as shown in Table 1. The preparation of sample AES-2 was performed in the same manner.
【0050】(1)泡性能の評価方法 熟練した専門家による官能評価により、泡立ち、泡の感
触などを総合的に評価し、下記判定基準に従って判定し
た。判定基準 ○;泡性能が良好である。 ×;泡性能が良くない。(1) Method of Evaluating Foam Performance Foaming, the feel of foam, and the like were comprehensively evaluated by sensory evaluation by a trained expert, and evaluated according to the following criteria. Criteria基準: good foam performance. ×: Poor foam performance.
【0051】(2)毛髪又は皮膚への殺菌効果を有する
化合物(殺菌性化合物)の滞留性の評価方法 それぞれ処方した組成物について、毛髪又は皮膚に使用
した後、毛髪又は皮膚に吸着した殺菌成分をそれぞれの
殺菌成分をよく溶解する溶媒にてそれぞれ抽出し、液体
クロマトグラフィーにより、それぞれの殺菌成分の定量
法に従って定量して毛髪又は皮膚への残留量を求め、後
述する標準組成の使用時と比較して、残留量の多いもの
を滞留性良好(○)とし、残留量が同じか少なくものを
滞留性不良(×)とした。(2) Method of evaluating the retention of a compound having a bactericidal effect on hair or skin (bactericidal compound) A bactericidal component adsorbed on hair or skin after using each of the formulated compositions for hair or skin. Is extracted with a solvent that dissolves each bactericidal component well, and liquid chromatography is used to determine the amount of each bactericidal component remaining in the hair or skin by quantifying according to the quantification method for each bactericidal component. In comparison, those having a large residual amount were evaluated as having good retention (性), and those having the same or small residual amount were evaluated as having poor retention (×).
【0052】ここで用いた標準組成は、エチレンオキシ
ド付加モル数の分布の広い表1のAES−1であるポリ
オキシエチレン(3モル)ラウリルエーテル硫酸ナトリ
ウム塩を10%、殺菌成分として、市販のピロクトンオ
ラミン(Clariant社製;オクトピロックス)
0.1%、残部精製水、合計100%というものであ
る。The standard composition used here is 10% of polyoxyethylene (3 mol) lauryl ether sulfate sodium salt, which is AES-1 in Table 1 having a wide distribution of the number of moles of ethylene oxide added. Cuton olamine (Clariant; Octopirox)
0.1% and the balance of purified water are 100% in total.
【0053】(3)マイルド性の評価方法 敏感肌パネル10名が組成物を使用したときの刺激感を
上述の標準組成と比較評価し、下記評価基準に従って判
定した。判定基準 〇;刺激感が標準組成と比較して、小さい。 △;刺激感が標準組成と比較して同等である。 ×;刺激感が標準組成と比較して、大きい。(3) Mildness evaluation method Ten sensational panelists used the composition to compare and evaluate the irritability when the composition was used with the above-mentioned standard composition, and evaluated the evaluation according to the following evaluation criteria. Judgment criterion 〇: Irritation was small compared to the standard composition. Δ: Irritation is equivalent to that of the standard composition. X: The irritability is large as compared with the standard composition.
【0054】(4)保存安定性の評価方法 40℃、1ケ月の高温条件での保存及び−5℃、1ケ月
の低温条件での保存の結果、目視観察によって、調製直
後のものと比べてほとんど変化が認められないものにつ
いて保存安定性を○とし、著しい変色や、析出、分離な
どが認められたものについて保存安定性を×とした。(4) Method of evaluating storage stability As a result of storage at 40 ° C. for one month under high-temperature conditions and -5 ° C. for one month under low-temperature conditions, the results were compared with those immediately after preparation by visual observation. The storage stability was evaluated as "O" when little change was observed, and the storage stability was evaluated as "X" when remarkable discoloration, precipitation and separation were observed.
【0055】(5)組成物の粘性の評価方法 組成物の粘度をブルックフィールドBL型粘度計で25
℃において測定し、下記判定基準に従って、粘性を評価
した。判定基準 ○;粘性が適度(10mPa・s以上)である。 ×;粘性が低い(10mPa・s未満)。(5) Method of Evaluating Viscosity of Composition The viscosity of the composition was measured using a Brookfield BL viscometer.
C. and the viscosity was evaluated according to the following criteria. Judgment standard : Viscosity is moderate (10 mPa · s or more). ×: Low viscosity (less than 10 mPa · s).
【0056】[0056]
【表1】 [Table 1]
【0057】[0057]
【表2】 [Table 2]
【0058】表2の結果からも明らかなように、本発明
の組成物は、いずれも優れた泡性能、毛髪又は皮膚への
滞留性、マイルド性、保存安定性を有し、使用時の粘性
が良好である。As is clear from the results shown in Table 2, the compositions of the present invention all have excellent foaming performance, retention on hair or skin, mildness, storage stability, and viscosity during use. Is good.
【0059】なお、表2においてB−1〜B−6で示し
た殺菌効果を有する化合物は、以下の通りである。The compounds having a bactericidal effect indicated by B-1 to B-6 in Table 2 are as follows.
【0060】[0060]
【化2】 Embedded image
【0061】[0061]
【化3】 Embedded image
【0062】B−3 サリチル酸 B−4 トリクロサン B−5 塩化ベンザルコニウム B−6 イソチアゾリン液(「ケーソンCG」:ローム
&ハース社製) なお、これらの化合物は、表2及び以下の実施例に共通
である。B-3 Salicylic acid B-4 Triclosan B-5 Benzalkonium chloride B-6 Isothiazoline liquid ("Caisson CG", manufactured by Rohm & Haas) These compounds are listed in Table 2 and the following Examples. It is common.
【0063】 [実施例7] 組成 A−1 15.0 ラウリン酸アミドプロピルベタイン 2.0 アルキルジメチルアミンオキシド 2.0 ヤシ油脂肪酸ジエタノールアミド 3.0 POEジオレイン酸メチルグルコシド 0.8 ラウリルピロリドン 3.0 B−1 0.5 コレウス抽出物 0.2 POE硬化ヒマシ油(HLB9) 1.5 POE(15モル)アルキルエーテル 0.5 硫酸ナトリウム 2.0 安息香酸ナトリウム 1.0 ジステアリン酸エチレングリコール 2.0 グリセリン脂肪酸エステル 0.2 グリシン 0.5 1,3−ブチレングリコール 1.0 ジブチルヒドロキシトルエン 0.005 オキシベンゾン 0.5 B−6 0.03 黄色203号 0.001 橙色205号 0.002 香料 0.7 クエン酸 0.5精製水 残部 合計 100 %Example 7 Composition A-1 15.0 Amidopropyl betaine laurate 2.0 Alkyl dimethylamine oxide 2.0 Palm oil fatty acid diethanolamide 3.0 POE Methyl glucoside dioleate 0.8 Laurylpyrrolidone 3. 0 B-1 0.5 Coleus extract 0.2 POE hydrogenated castor oil (HLB9) 1.5 POE (15 mol) alkyl ether 0.5 Sodium sulfate 2.0 Sodium benzoate 1.0 Ethylene glycol distearate 2. 0 Glycerin fatty acid ester 0.2 Glycine 0.5 1,3-butylene glycol 1.0 Dibutylhydroxytoluene 0.005 Oxybenzone 0.5 B-6 0.03 Yellow No. 203 0.001 Orange No. 205 0.002 Fragrance 0 .7 citric acid 0.5 purified water remaining balance 100%
【0064】上記組成のシャンプー組成物を常法に準じ
て調製した。このシャンプー組成物は、25℃における
粘度が10mPa・s以上であり、泡立ち、泡感触に優
れ、マイルドであり、毛髪へのB−1、B−6化合物の
滞留性に優れており、保存安定性も良好で、使用時の粘
性も低すぎることなく適度であった。A shampoo composition having the above composition was prepared according to a conventional method. This shampoo composition has a viscosity at 25 ° C. of 10 mPa · s or more, is excellent in foaming, foam feeling, mild, has excellent retention of B-1 and B-6 compounds on hair, and is stable in storage. The properties were good, and the viscosity during use was moderate without being too low.
【0065】 [実施例8] 組成 A−2 15.0 α−オレフィンスルホン酸ナトリウム 2.0 アルカンスルホン酸ナトリウム 5.0 ラウリン酸アミドプロピルベタイン 3.0 アルキルカルボキシエチルヒドロキシエチル イミダゾリニウムベタイン 1.0 POEラウロイルスルホコハク酸ナトリウム 0.5 アルキルジメチルアミンオキシド 0.2 POE(20)ラウリルエーテル 2.0 B−3 0.2 ワックス 0.5 塩化ナトリウム 0.2 トリメチルグリシン 0.2 カロフィリス抽出物 0.5 イソプロピルメチルフェノール 1.0 エデト酸二ナトリウム 2.0 塩化アルキルジメチルアンモニウム/アクリル酸 /アクリルアミド三元重合体 0.6 グリセリン 0.1 メトキシ桂皮酸2−エチルヘキシル 0.5 色素 0.1 香料 0.3 クエン酸 3.0 グリコール酸 3.0精製水 残部 合計 100 %Example 8 Composition A-2 15.0 Sodium α-Olefin Sulfonate 2.0 Sodium Alkane Sulfonate 5.0 Amidopropyl Betaine Laurate 3.0 Alkyl Carboxyethyl Hydroxyethyl Imidazolinium Betaine 1. 0 POE sodium lauroyl sulfosuccinate 0.5 alkyldimethylamine oxide 0.2 POE (20) lauryl ether 2.0 B-3 0.2 wax 0.5 sodium chloride 0.2 trimethylglycine 0.2 calophyllis extract 5 Isopropylmethylphenol 1.0 Disodium edetate 2.0 Alkyldimethylammonium chloride / acrylic acid / acrylamide terpolymer 0.6 Glycerin 0.1 2-Ethylhexyl methoxycinnamate 0.5 Dye 0.1 Aroma 0.3 Citric acid 3.0 glycolic acid 3.0 Purified water balance Total 100%
【0066】上記組成に従ってシャンプー組成物を常法
に準じて調製した。このシャンプー組成物は、25℃に
おける粘度が10mPa・s以上であり、優れた泡性
能、マイルド性、B−3化合物の頭皮への滞留性を有し
ており、保存安定性に優れ、適度な粘性を有していた。According to the above composition, a shampoo composition was prepared according to a conventional method. This shampoo composition has a viscosity at 25 ° C. of 10 mPa · s or more, has excellent foaming performance, mild properties, and a property of retaining the B-3 compound on the scalp, has excellent storage stability, and has a moderate storage stability. It had viscosity.
【0067】 [実施例9] 組成 A−1 7.0 ミリスチン酸カリウム 15.0 パルミチン酸 8.0 ステアリン酸 8.0 B−1 0.5 B−3 0.2 オレイルアルコール 1.0 グリセリン 10.0 ポリエチレングリコール 5.0 ヤシ油脂肪酸モノエタノールアミド 0.1 プロピレングリコール 1.0 植物性スクワラン 0.5 エデト酸4ナトリウム4水塩 0.2 POE硬化ヒマシ油(HLB9) 1.5 グリセリン脂肪酸エステル 0.2 ベンクレー 0.8 イソプレングリコール 1.0 青色403号 0.001 香料 0.2精製水 残部 合計 100 %Example 9 Composition A-1 7.0 Potassium myristate 15.0 Palmitic acid 8.0 Stearic acid 8.0 B-1 0.5 B-3 0.2 Oleyl alcohol 1.0 Glycerin 10 0.0 Polyethylene glycol 5.0 Coconut oil fatty acid monoethanolamide 0.1 Propylene glycol 1.0 Vegetable squalane 0.5 Edetate tetrasodium tetrahydrate 0.2 POE hydrogenated castor oil (HLB9) 1.5 Glycerin fatty acid ester 0.2 Benclay 0.8 Isoprene glycol 1.0 Blue No. 403 0.001 Fragrance 0.2 Purified water Remainder 100%
【0068】上記組成に従って、常法に準じて洗顔剤組
成物を調製した。この洗顔剤組成物は、25℃における
粘度が10mPa・s以上であり、泡性能が良好で、B
−1及びB−3化合物の皮膚への滞留性に優れ、マイル
ドでかつ保存安定性が良好であり、適度な粘性を有し、
使い勝手が良好であった。According to the above composition, a face wash composition was prepared according to a conventional method. This facial cleansing composition has a viscosity at 25 ° C. of 10 mPa · s or more, good foaming performance,
-1 and B-3 compounds are excellent in retention in skin, mild and have good storage stability, have appropriate viscosity,
The usability was good.
【0069】 [実施例10] 組成 A−1 5.0 アシルメチルタウリンナトリウム 5.5 アルキルベタイン 3.0 POEアルキルエーテル 6.5 アルキルグリセログルコシド 1.0 塩化ジメチルジアリルアンモニウムとアクリル酸との共重合体 0.7 POEジオレイン酸メチルグルコシド 1.0 ヤシ油脂肪酸ジエタノールアミド 3.0 ヤシ油脂肪酸モノエタノールアミド 1.0 B−1 0.5 B−2 0.2 ピリチオン亜鉛 1.0 ジステアリン酸エチレングリコール 2.0 ラウリルピロリドン 5.0 イソオクタン酸セチル 1.0 ジブチルヒドロキシトルエン 0.002 グリチルレチン酸 0.5 ゼニアオイエキス 0.5 高重合ジメチルポリシロキサン 3.0 セトステアリルアルコール 0.1 酢酸トコフェロール 0.5 色素 0.002 香料 0.2精製水 残部 合計 100 %Example 10 Composition A-1 5.0 Sodium Acylmethyl Taurine 5.5 Alkyl Betaine 3.0 POE Alkyl Ether 6.5 Alkyl Glyceroglucoside 1.0 Co-Polymerization of Dimethyl Diallylammonium Chloride and Acrylic Acid Merged 0.7 POE methyl glucoside dioleate 1.0 Coconut fatty acid diethanolamide 3.0 Coconut fatty acid monoethanolamide 1.0 B-1 0.5 B-2 0.2 Zinc pyrithione 1.0 Ethylene glycol distearate 2.0 laurylpyrrolidone 5.0 cetyl isooctanoate 1.0 dibutylhydroxytoluene 0.002 glycyrrhetinic acid 0.5 mallow extract 0.5 highly polymerized dimethylpolysiloxane 3.0 cetostearyl alcohol 0.1 tocopherol acetate 0.5 Containing 0.002 Perfume 0.2 Purified water balance Total 100%
【0070】上記組成に従って、シャンプー組成物を常
法に準じて調製した。このシャンプー組成物は、25℃
における粘度が10mPa・s以上であり、泡性能、マ
イルド性に優れ、B−1、B−2化合物及びピリチオン
亜鉛の皮膚への良好な滞留性を有し、また、その粘性は
適度であり、使用性の良い組成物であった。According to the above composition, a shampoo composition was prepared according to a conventional method. This shampoo composition has a temperature of 25 ° C.
Is 10 mPa · s or more, foaming performance, excellent in mildness, B-1 and B-2 compounds and zinc pyrithione have good retention properties on the skin, and the viscosity is moderate, The composition had good usability.
【0071】 [実施例11] 組成 A−2 5.0 アシルメチル−β−アラニントリエタノールアミン 10.0 アシルグルタミン酸トリエタノールアミン 5.0 エーテルカルボン酸ナトリウム 1.0 アルキルアミノプロピオン酸 0.05 ラウリルジメチルアミンオキシド 0.8 塩化ステアリルトリメチルアンモニウム 1.0 パーム核油脂肪酸ジエタノールアミド 2.0 POE硬化ヒマシ油(HLB9) 3.0 プロピレングリコール 0.2 エタノール 3.0 グリチルリチン酸ジカリウム 0.3 B−1 1.5 流動パラフィン 0.2 グリセリン脂肪酸エステル 0.8 安息香酸ナトリウム 0.7 加水分解タンパク 0.5 硫酸マグネシウム 1.5 カチオン化セルロース 0.2 塩化アルキルジメチルアンモニウム/アクリル酸共重合体 0.4 ジブチルヒドロキシトルエン 0.2 香料 0.3 クエン酸 0.1 エデト酸 1.0精製水 残部 合計 100 %Example 11 Composition A-2 5.0 Acylmethyl-β-alanine triethanolamine 10.0 Triethanolamine acylglutamate 5.0 Sodium ether carboxylate 1.0 Alkylaminopropionic acid 0.05 Lauryldimethyl Amine oxide 0.8 Stearyl trimethylammonium chloride 1.0 Palm kernel oil fatty acid diethanolamide 2.0 POE hydrogenated castor oil (HLB9) 3.0 Propylene glycol 0.2 Ethanol 3.0 Dipotassium glycyrrhizinate 0.3 B-11 .5 Liquid paraffin 0.2 Glycerin fatty acid ester 0.8 Sodium benzoate 0.7 Hydrolyzed protein 0.5 Magnesium sulfate 1.5 Cationized cellulose 0.2 Alkyl dimethyl ammonium chloride / acrylic acid copolymer Combined 0.4 Dibutylhydroxytoluene 0.2 Fragrance 0.3 Citric acid 0.1 Edetic acid 1.0 Purified water Remainder 100%
【0072】上記組成に従ってシャンプー組成物を常法
に準じて調製した。このシャンプー組成物は、25℃に
おける粘度が10mPa・s以上であり、泡立ち、泡感
触に優れ、マイルドであり、毛髪へのB−1化合物の滞
留性に優れており、保存安定性も良好で、使用時の粘性
も低すぎることなく適度であった。According to the above composition, a shampoo composition was prepared according to a conventional method. This shampoo composition has a viscosity at 25 ° C. of 10 mPa · s or more, foams, has an excellent foam feeling, is mild, has excellent retention of the B-1 compound on hair, and has good storage stability. The viscosity during use was moderate without being too low.
【0073】 [実施例12] 組成 A−2 7.0 ミリスチン酸カリウム 15.0 ラウロイルメチル−β−アラニンカリウム塩 2.0 ラウロイルグルタミン酸モノカリウム塩 2.0 ラウリルジメチルアミンオキシド 1.0 B−1 0.5 B−4 0.2 オレイルアルコール 1.0 ポリエチレングリコール 5.0 ヤシ油脂肪酸ジエタノールアミド 3.0 プロピレングリコール 6.0 ヒドロキシプロピルメチルセルロース*1 0.5 植物性スクワラン 0.5 エデト酸4ナトリウム4水塩 0.2 POE硬化ヒマシ油(HLB9) 1.5 ベンクレー 0.8 水酸化カリウム 微量 青色403号 0.001 香料 0.2精製水 残部 合計 100 % *1 信越化学工業(株) メトロース 65SH−1500Example 12 Composition A-2 7.0 Potassium myristate 15.0 Lauroylmethyl-β-alanine potassium salt 2.0 Monopotassium lauroylglutamate 2.0 Lauryldimethylamine oxide 1.0 B-1 0.5 B-4 0.2 Oleyl alcohol 1.0 Polyethylene glycol 5.0 Coconut oil fatty acid diethanolamide 3.0 Propylene glycol 6.0 Hydroxypropyl methylcellulose * 1 0.5 Vegetable squalane 0.5 Sodium edetate Tetrahydrate 0.2 POE hydrogenated castor oil (HLB9) 1.5 Benclay 0.8 Potassium hydroxide trace amount Blue 403 0.001 Fragrance 0.2 Purified water Remainder 100% * 1 Shin-Etsu Chemical Co., Ltd. Metroose 65SH -1500
【0074】上記組成に従って、皮膚洗浄剤組成物を常
法に準じて調製した。この皮膚洗浄剤組成物は、25℃
における粘度が10mPa・s以上であり、泡性能が良
好で、B−1及びB−4化合物の皮膚への滞留性に優
れ、マイルドでかつ保存安定性が良好であり、適度な粘
性を有し、使い勝手が良好であった。According to the above composition, a skin cleansing composition was prepared according to a conventional method. This skin cleansing composition is at 25 ° C.
Is 10 mPa · s or more, the foaming performance is good, the retention of B-1 and B-4 compounds on the skin is excellent, mild and has good storage stability, and has an appropriate viscosity. And the usability was good.
【0075】 [実施例13] A−1 4.0 A−2 2.0 ミリスチン酸カリウム 16.0 パルミチン酸 5.0 ステアリン酸 5.0 B−1 0.8 B−5 0.3 局方イオウ 5.0 オレイルアルコール 1.0 グリセリン 15.0 ポリエチレングリコール 4000 5.0 ヤシ油脂肪酸ジエタノールアミド 1.1 プロピレングリコール 1.0 カロフィリス抽出物 0.5 エデト酸4ナトリウム4水塩 0.2 ベンクレー 0.8 香料 0.3精製水 残部 合計 100 %Example 13 A-1 4.0 A-2 2.0 Potassium myristate 16.0 Palmitic acid 5.0 Stearic acid 5.0 B-1 0.8 B-5 0.3 Pharmacopoeia Sulfur 5.0 Oleyl alcohol 1.0 Glycerin 15.0 Polyethylene glycol 4000 5.0 Coconut oil fatty acid diethanolamide 1.1 Propylene glycol 1.0 Carophyllis extract 0.5 Edeoic acid tetrasodium tetrahydrate 0.2 Benclay 0 .8 Perfume 0.3 Purified water Remainder 100%
【0076】上記組成に従って、洗顔剤組成物を常法に
準じて調製した。この洗顔剤組成物は、25℃における
粘度が10mPa・s以上であり、泡性能が良好で、B
−1及びB−5化合物、局方イオウの皮膚への滞留性に
優れ、マイルドでかつ保存安定性が良好であり、適度な
粘性を有し、使い勝手が良好であった。According to the above composition, a face wash composition was prepared according to a conventional method. This facial cleansing composition has a viscosity at 25 ° C. of 10 mPa · s or more, good foaming performance,
-1 and B-5 compounds and sulfur were excellent in staying in the skin, mild, had good storage stability, had appropriate viscosity, and were easy to use.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A01N 43/80 102 A01N 43/80 102 4H011 A61K 7/06 A61K 7/06 7/075 7/075 7/50 7/50 31/085 31/085 31/14 31/14 31/198 31/198 31/425 31/425 31/44 31/44 31/4418 31/4418 31/60 31/60 31/67 31/67 33/04 33/04 47/20 47/20 A61P 31/04 A61P 31/04 C11D 3/48 C11D 3/48 Fターム(参考) 4C076 AA17 BB31 CC18 DD37A DD37R DD38A DD39F DD43Z DD46F DD47 DD51F DD52F DD55F DD57F EE51A 4C083 AA112 AB032 AB112 AB332 AB352 AB362 AB442 AC022 AC072 AC092 AC112 AC122 AC172 AC182 AC212 AC242 AC302 AC312 AC342 AC352 AC392 AC422 AC432 AC471 AC472 AC532 AC552 AC562 AC581 AC582 AC642 AC662 AC691 AC692 AC712 AC781 AC782 AC792 AC811 AC812 AC851 AC852 AC861 AC862 AD132 AD192 AD212 AD282 AD412 AD532 AD662 BB48 CC02 CC23 CC31 CC38 DD23 DD31 EE01 EE06 EE07 4C086 AA01 BC17 MA16 MA63 NA14 ZA89 ZA92 ZB35 4C206 AA01 CA28 MA03 MA05 MA36 MA83 NA14 ZA89 ZA92 ZB35 4H003 AB05 AB10 AB14 AB15 AB23 AB29 AB31 AB34 AC03 AC05 AC08 AC12 AC13 AC15 AD02 AD04 DA02 EA12 EB04 EB07 EB08 EB09 EB13 EB19 EB20 EB21 EB40 EB43 ED02 FA02 FA16 FA17 FA18 FA21 FA30 FA34 4H011 AA02 BA01 BB04 BB06 BB09 BB10 BB18 BC07 DG16 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A01N 43/80 102 A01N 43/80 102 4H011 A61K 7/06 A61K 7/06 7/075 7/075 7 / 50 7/50 31/085 31/085 31/14 31/14 31/198 31/198 31/425 31/425 31/44 31/44 31/4418 31/4418 31/60 31/60 31/67 31 / 67 33/04 33/04 47/20 47/20 A61P 31/04 A61P 31/04 C11D 3/48 C11D 3/48 F term (reference) 4C076 AA17 BB31 CC18 DD37A DD37R DD38A DD39F DD43Z DD46F DD47 DD51F DD52F DD55F DD57F EE51A 4C083 AA112 AB032 AB112 AB332 AB352 AB362 AB442 AC022 AC072 AC092 AC112 AC122 AC172 AC182 AC212 AC242 AC302 AC312 AC342 AC352 AC392 AC422 AC432 AC471 AC472 AC532 AC552 AC562 AC581 AC582 AC642 AC662 AC691 AC692 AC712 AC781 AC782 AC1 AC8212 AC782 AC1 AD412 AD532 AD662 BB48 CC02 CC23 CC31 CC38 DD23 DD31 EE01 EE06 EE07 4C086 AA01 BC17 MA16 MA63 NA14 ZA89 ZA92 ZB35 4C206 AA01 CA28 MA03 MA05 MA36 MA83 NA14 ZA89 ZA92 ZB35 4H003 AB05 AB10 AC14 AB15 AC23 AC29 DA02 EA12 EB04 EB07 EB08 EB09 EB13 EB19 EB20 EB21 EB40 EB43 ED02 FA02 FA16 FA17 FA18 FA21 FA30 FA34 4H011 AA02 BA01 BB04 BB06 BB09 BB10 BB18 BC07 DG16
Claims (3)
エチレンオキシド付加モル数のものを含み、エチレンオ
キシド付加モル数が0のものが占める質量%が最大値を
示すことがなく、最大値を示すエチレンオキシド付加体
の質量%が15〜35であり、この前後の付加モル数を
有するエチレンオキシド付加体との総量が55〜75質
量%であるアルキルエトキシサルフェート及び/又はそ
の塩と、b)殺菌性化合物とを含有し、25℃における
粘度が10mPa・s以上であることを特徴とする殺菌
性化合物含有組成物。 R1O−(CH2CH2O)n−SO3M …(1) (但し、上記式中、R1は、炭素数6〜24の直鎖状又
は分岐鎖状のアルキル基又はアルケニル基であり、n
は、エチレンオキシド基の平均付加モル数を示し、1〜
6の範囲であり、Mは、水素原子、アルカリ金属、アル
カリ土類金属、アルカノールアミン又はアンモニウムで
ある。)1. a) Including a compound represented by the following general formula (1) having a different number of moles of ethylene oxide added and having 0 moles of ethylene oxide added, the mass% occupied by the polymer does not show the maximum value, (B) sterilization, wherein the mass% of the ethylene oxide adduct having the following formula is from 15 to 35, and the total amount of the ethylene oxide adduct having an addition mole number before and after the alkyl ethoxy sulfate is from 55 to 75 mass%; A bactericidal compound-containing composition comprising a bactericidal compound and having a viscosity at 25 ° C. of 10 mPa · s or more. R 1 O— (CH 2 CH 2 O) n —SO 3 M (1) (where R 1 is a linear or branched alkyl or alkenyl group having 6 to 24 carbon atoms) And n
Represents the average number of moles of ethylene oxide group added,
6, and M is a hydrogen atom, an alkali metal, an alkaline earth metal, an alkanolamine or ammonium. )
リドン系化合物、サリチル酸及びその塩、ピリチオン亜
鉛類、トリクロロカルバニリド、トリクロサン、塩化ベ
ンザルコニウム、塩酸アルキルジアミノエチルグリシ
ン、メチルクロロイソチアゾリン・メチルイソチアゾリ
ン系殺菌剤及びイオウから選ばれる1種又は2種以上の
殺菌性化合物である請求項1記載の殺菌性化合物含有組
成物。2. The component (b) is a 1-hydroxy-2-pyridone compound, salicylic acid and a salt thereof, zinc pyrithione, trichlorocarbanilide, triclosan, benzalkonium chloride, alkyldiaminoethylglycine hydrochloride, methylchloroisothiazoline. The fungicidal compound-containing composition according to claim 1, which is one or more fungicidal compounds selected from a methylisothiazoline fungicide and sulfur.
1又は2記載の殺菌性化合物含有組成物。3. The bactericidal compound-containing composition according to claim 1, which is a composition for external use on hair or skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000130387A JP4025950B2 (en) | 2000-04-28 | 2000-04-28 | Bactericidal compound-containing composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000130387A JP4025950B2 (en) | 2000-04-28 | 2000-04-28 | Bactericidal compound-containing composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001311092A true JP2001311092A (en) | 2001-11-09 |
JP4025950B2 JP4025950B2 (en) | 2007-12-26 |
Family
ID=18639507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000130387A Expired - Fee Related JP4025950B2 (en) | 2000-04-28 | 2000-04-28 | Bactericidal compound-containing composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4025950B2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007145748A (en) * | 2005-11-28 | 2007-06-14 | Mandom Corp | Antiseptic disinfectant, cosmetics or medicines containing the antiseptic disinfectant, and antiseptic disinfection method |
JP2008110999A (en) * | 2008-02-04 | 2008-05-15 | Mandom Corp | Antibacterial composition and deodorant agent |
JP2009007283A (en) * | 2007-06-27 | 2009-01-15 | Lion Corp | Hair cosmetic |
WO2009075142A1 (en) * | 2007-12-12 | 2009-06-18 | Lion Corporation | Bactericidal cleanser composition |
JP2010030987A (en) * | 2008-07-24 | 2010-02-12 | Rohm & Haas Co | Method for reducing odor in personal care product |
JP2010121032A (en) * | 2008-11-19 | 2010-06-03 | Nof Corp | Detergent composition |
JP2012136443A (en) * | 2010-12-24 | 2012-07-19 | Kao Corp | Skin-sterilizing cleanser composition |
JP2013082846A (en) * | 2011-10-12 | 2013-05-09 | Kao Corp | Dishwashing detergent composition for hand washing |
JP2013082844A (en) * | 2011-10-12 | 2013-05-09 | Kao Corp | Composition of agent for washing dishes by hand |
JP2016108411A (en) * | 2014-12-04 | 2016-06-20 | クラシエホームプロダクツ株式会社 | Detergent composition |
CN105997546A (en) * | 2015-03-31 | 2016-10-12 | 日油株式会社 | Body cleansing composition |
JP2016540733A (en) * | 2013-10-24 | 2016-12-28 | デラヴァル ホルディング アーベー | Antibacterial composition |
CN106577650A (en) * | 2016-12-14 | 2017-04-26 | 广州泰晟生物科技有限公司 | Triclosan effervescent preparation and preparation method thereof |
CN106860035A (en) * | 2015-11-17 | 2017-06-20 | 日油株式会社 | Surface activator composition |
JP2019099821A (en) * | 2017-12-06 | 2019-06-24 | 花王株式会社 | Liquid washing agent composition for textile product |
JP2020002110A (en) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | Liquid cleaning composition and use thereof |
-
2000
- 2000-04-28 JP JP2000130387A patent/JP4025950B2/en not_active Expired - Fee Related
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007145748A (en) * | 2005-11-28 | 2007-06-14 | Mandom Corp | Antiseptic disinfectant, cosmetics or medicines containing the antiseptic disinfectant, and antiseptic disinfection method |
JP2009007283A (en) * | 2007-06-27 | 2009-01-15 | Lion Corp | Hair cosmetic |
JP5343857B2 (en) * | 2007-12-12 | 2013-11-13 | ライオン株式会社 | Bactericidal detergent composition |
WO2009075142A1 (en) * | 2007-12-12 | 2009-06-18 | Lion Corporation | Bactericidal cleanser composition |
CN101896595B (en) * | 2007-12-12 | 2012-04-25 | 狮王株式会社 | Bactericidal cleanser composition |
KR101443951B1 (en) | 2007-12-12 | 2014-09-23 | 라이온 가부시키가이샤 | Bactericidal cleanser composition |
JP2008110999A (en) * | 2008-02-04 | 2008-05-15 | Mandom Corp | Antibacterial composition and deodorant agent |
JP2010030987A (en) * | 2008-07-24 | 2010-02-12 | Rohm & Haas Co | Method for reducing odor in personal care product |
JP2010121032A (en) * | 2008-11-19 | 2010-06-03 | Nof Corp | Detergent composition |
JP2012136443A (en) * | 2010-12-24 | 2012-07-19 | Kao Corp | Skin-sterilizing cleanser composition |
JP2013082844A (en) * | 2011-10-12 | 2013-05-09 | Kao Corp | Composition of agent for washing dishes by hand |
JP2013082846A (en) * | 2011-10-12 | 2013-05-09 | Kao Corp | Dishwashing detergent composition for hand washing |
JP2016540733A (en) * | 2013-10-24 | 2016-12-28 | デラヴァル ホルディング アーベー | Antibacterial composition |
JP2016108411A (en) * | 2014-12-04 | 2016-06-20 | クラシエホームプロダクツ株式会社 | Detergent composition |
CN105997546A (en) * | 2015-03-31 | 2016-10-12 | 日油株式会社 | Body cleansing composition |
CN105997546B (en) * | 2015-03-31 | 2020-07-14 | 日油株式会社 | Body wash composition |
CN106860035A (en) * | 2015-11-17 | 2017-06-20 | 日油株式会社 | Surface activator composition |
CN106577650A (en) * | 2016-12-14 | 2017-04-26 | 广州泰晟生物科技有限公司 | Triclosan effervescent preparation and preparation method thereof |
JP2019099821A (en) * | 2017-12-06 | 2019-06-24 | 花王株式会社 | Liquid washing agent composition for textile product |
JP2020002110A (en) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | Liquid cleaning composition and use thereof |
JP7146489B2 (en) | 2018-06-29 | 2022-10-04 | 小林製薬株式会社 | Liquid cleaning composition and its use |
Also Published As
Publication number | Publication date |
---|---|
JP4025950B2 (en) | 2007-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6449544B2 (en) | Cleaning composition | |
JP4025950B2 (en) | Bactericidal compound-containing composition | |
JP5041894B2 (en) | Cleaning composition | |
JP5615515B2 (en) | Cleaning composition | |
JPH08239312A (en) | Hair shampoo composition | |
JP2007277227A (en) | Cleaning composition containing azole antifungal agent | |
EP1842572A2 (en) | Hair cleansing composition | |
JP5748681B2 (en) | Transparent liquid cleaning material | |
JP2007131687A (en) | Transparent detergent composition | |
JPH0794674B2 (en) | Cleaning composition | |
WO2006093311A1 (en) | Detergent composition | |
JP2004217614A (en) | Detergent composition | |
JP3545372B2 (en) | Skin cleansing composition | |
JP2006298916A (en) | Hair cleanser composition | |
JP2021147327A (en) | Skin detergent compositions | |
KR20060009895A (en) | Detergent composition | |
JPH0633405B2 (en) | Cleaning composition | |
JP4790173B2 (en) | Cleaning composition | |
EP0826766A2 (en) | Wash composition | |
JP2000129300A (en) | Detergent composition | |
JPH0240316A (en) | Shampoo composition | |
JP2000129298A (en) | Detergent composition | |
JPH0940996A (en) | Detergent composition | |
JP2002029939A (en) | Shampoo composition | |
JPH07330553A (en) | Hair cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040914 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051102 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051130 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070620 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070817 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070912 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070925 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101019 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101019 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111019 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111019 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121019 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |